Point Values, Reimbursement Of Health Care Covered By Insurance R.2009

Original Language Title: Hodnoty bodu, úhrady zdravotní péče hrazené z pojištění pro r.2009

Read the untranslated law here: https://portal.gov.cz/app/zakony/download?idBiblio=67650&nr=464~2F2008~20Sb.&ft=txt

464/2008 Coll.
DECREE


Dated December 18, 2008

Establishing point values, the amount of payment for health care covered by public health insurance
and regulatory restrictions on the volume
provided health care covered by public health insurance in 2009

Ministry of Health determined in accordance with § 17 para. 6 of the Act no. 48/1997
Coll., On public health insurance and amending and supplementing some
related laws, as amended by Act no. 117/2006 Coll. no. 245/2006 Coll.
And no. 261/2007 Coll .:

§ 1

(1) This Regulation establishes for 2009 point values, the amount of reimbursement of healthcare provided
insured under § 2 par. 1 of Law no.
48/1997 Coll., On Public Health Insurance and Amendments
some related laws, as amended (hereinafter
"Act") and policyholders from other Member States of the European Union,
European economic area and Switzerland in accordance with the relevant regulations of the European Communities
^ 1) policyholders and other states
with which the Czech Republic has concluded international agreements on social security
^ 2) (hereinafter 'the insured from EU ")
covered by public health insurance and regulatory restrictions on the volume of health care
for payment methods specified in § 2-15, provided

A) contractual institutional healthcare facilities, including
specialized medical institutions, hospitals, long term sick
healthcare facilities reporting day of treatment no. 00005 by
decree is issued a list of medical procedures with point | || values ​​^ 3) (hereinafter "the list of duties") and medical devices
hospice type pursuant to § 22a of the Act

B) contractual practitioners and general practitioners for children and adolescents,

C) in contractual outpatient healthcare facilities providing
specialized outpatient medical care, including outpatient
health care facilities providing health care and hemodialysis
orthoptic health care

D) in contractual outpatient healthcare facilities providing
health care in specializations 603 and 604 according to the list of operations,

E) contracting dentists

F) in contractual outpatient healthcare facilities providing
health care in specializations 222, 801, 802, 804, 805, 807, 809, 812
up to 819, 822 and 823 according to the list of operations (hereinafter "listed
expertise ")

G) in contractual outpatient healthcare facilities providing
health care in specializations 911, 914, 921 and 925 according to the list of operations,

H) in contractual outpatient healthcare facilities providing health care
expertise 902 list performances

I) contractual health care facilities of emergency medical services, transportation and health
providing medical first aid service,

J) contractual health care facilities spa treatment and convalescent homes,

K) as part of emergency medical care in a non-contracting
medical devices.

(2) Where the medical facilities and health insurance
agree on another method of payment than mentioned in § 2-14, the agreed amount of payment
according to this method of payment may be in conflict with health insurance || | health insurance plan.

§ 2

For healthcare provided medical devices specified in §
1. 1 point. b), d), e) and k), paid for by the list of operations, including
health care provided to insured persons from the EU down the point value of CZK 0.95
amount, unless stated otherwise.

§ 3

(1) For healthcare provided by healthcare facilities
institutional care, with the exception of health care provided in specialized medical
institutions, long-term care patients in healthcare facilities reporting day of treatment
no. 00005 list performance and in health care facilities
hospice type a point value, the amount of reimbursement
health care and regulatory restrictions laid down in Annexes Nos. 1, 9 and 10 to
hereto.

(2) For health care provided in specialized medical institutions,
long-term care patients in healthcare facilities reporting day of treatment
no. 00005 list performances, and
medical facilities hospice type paid a lump
rate for one day hospitalization or list performances, a point value,

Level of reimbursement of health care and regulatory restrictions laid down in Annex no. 1 to
hereto.

§ 4

For health care provided by GPs and GPs
for children and adolescents, paid a combined power capitation payment,
combined capacity- performance payment of capitation or by calling
list performances, a point value, the amount of reimbursements
health care and regulatory restrictions laid down in Annex no. 2 hereto.

§ 5

For specialized outpatient healthcare provided in outpatient healthcare facilities
, paid for by the list of performances
a point value, the amount of payment for health care and regulatory restrictions
down in Annex no. 3 hereto.

§ 6

For outpatient healthcare provided in outpatient healthcare facilities in
specializations 603 and 604 list
performance, paid for by the list of operations, the value of the item, the amount of reimbursement
health care and regulatory restrictions laid down in Annex .
4 to this Decree.

§ 7

(1) For health care provided by dentists, paid for by
list of operations, the point value determined in § 2.

(2) Health care provided by dentists reimbursed pursuant to paragraph 1
shall be paid by the contractual arrangements between health insurers and health facilities
, if the conditions stipulated in the contract.
The amount of the reimbursement of such care is provided in Annex no. 11 to this
decree, in accordance with regulations regulating prices; 4).

(3) Health Insurance is entitled to limit the total amount of reimbursement
medical facilities so that the total amount of payment for health care provided by dentists
in 2009 did not exceed the amount specified in
health insurance plan for health insurance
health care provided by dentists. If they exceeded the total amount of payment for
health care provided by dentists, set in
health insurance plan health insurance for the healthcare, it was caused
providing more necessary and urgent health care
compared to 2008 , health insurance, this larger volume accounted for in
payment.

§ 8

For health care provided by outpatient health care facilities
in listed specializations, paid for by the list of operations, the
point value and the level of reimbursement of health care provided in Annex no. 5 to this Decree
.

§ 9

For healthcare provided outpatient medical facilities in specialties
911, 914, 921 and 925 according to the list of achievements, paid for by
list of operations, the value of the item and the amount of reimbursement of healthcare down in Annex
. 6 hereto.

§ 10

For health care provided by outpatient health care facilities in expertise
902 list performances, paid for by the list of performances
a point value and the level of reimbursement of health care provided in Annex no. 7 to
hereto.

§ 11

For health care provided in the framework of the emergency medical services paid for by
list of operations, establishing a point value in the amount of CZK 1.06, with the exception of performances
06713 and 79202 according to the list of achievements for which || | point value determined in the amount of CZK 1.03.

§ 12

For the performance of the health service, funded by the list of operations, the value
point and the level of reimbursement of health care provided in Annex no. 8 of this Decree
.

§ 13

For health care provided in the framework of first aid medical services, paid for by
list of operations, establishing a point value in the amount of CZK 0.95.

§ 14

Spa care provided by medical facilities and spa treatments
healthcare provided in sanatoria is paid by
contractual arrangements between health insurers and health facilities.

§ 15

For health care provided in the framework of emergency medical care in
non-contractual healthcare facilities, paid for by the list of operations,
the point value determined in § 2.

§ 16

This decree comes into force on 1 January 2009.
Minister
:

MD. Julínek, MBA vr
Appendix 1


Point value, the amount of reimbursement of health care and regulatory restrictions under § 3

A) Residential care under § 3 para. 1

First Reimbursement of medical equipment in 2009 includes individual ingredients
the contractually agreed payment, lump sum payment for ingredient

Inpatient care reimbursement fee in the form of a case and outpatient component
payment. The reference period is the year 2008. In the reference period is included
all health care provided in 2008
medical facility reported in March 31, 2009 and recognized by health insurance
to 05/31/2009.

Second Individually contractually agreed remuneration component includes
payment for health care, included in the Classification of hospitalized patients
^ 5) (hereinafter referred to as the "Classification") into groups related to the diagnosis:

A), 08021, 08022, 08023, 08041, 08042, 08043, 08181, 08182, 08183,

B) 05011, 05012, 05013, 05070, 05161, 05162, 05163, 05111, 05112, 05113
,

C) 02041, 02042, 02043,

Listed in Annex no. 9 (hereinafter "the listed groups") and payment for
medicines and foods for special medical purposes (hereinafter
"Medicines") paid in 2009 for specialized || | work in accordance with § 15 para. 7 point. b) of the Act. The amount and method of payment
this health care health insurance contractually agree
health facilities. If health insurance is a medical device
agree individually contractually agreed payment component may include reimbursement
other health care than is stated in the first sentence;
in this case, this payment as well as reimbursement for health care
classification according to the classification listed groups not included in the
payment referred to in point 3.

Third Flat-rate component payment for inpatient care (PUhosp2009) for
2009 the procedure set out in paragraphs 3.1 to 3.6.

3.1 Flat-rate component payment for inpatient care (PUhosp2009)
is determined as follows:


PUhosp2009 = [PUhosp2008 - (CMalfa2008 * IRS alfa2008)] * Kn

PUhosp2008 = Vhosp * ICBref ZUMhosp + + + ZULPhosp LPhosp KPhosp +

Where
:


Vhosp total number of recognized medical facility and health insurance recognized
points over the reference period for procedures performed
hospitalizations during the reference period, after deducting points for
reference period for treatment (including
performance in listed specializations and consult with examinations, according to the list of performances)
performed during hospitalizations in the reference period are included in the Classification
included in the enumerated categories listed in section 2;
number of points according to the first sentence shall be converted according to the list of valid performances 1.1.2009


ICBref calculated individual price point of medical devices that
determined as a proportion Uref / Bref, where:


Uref total remuneration attributable medical equipment for all medical
care provided in the reference period for the settlement of all regulatory
measures, with the exception of regulation for prescribed medicines and medical devices
, reduced reimbursement for separately billed
medicinal products and separately charged material provided in the reference period
declared a health insurance company recognized in connection with the care of patients
, a lump sum which is paid by the Medicines §
17 paragraph. 7 of the Act, and other reimbursement of health care costs paid in
crowns (KPref)


Bref total number of recognized medical facility and health insurance recognized
points, converted according to the current list of achievements
January 1, 2009, for health care provided in the reference period


ZUMhosp total amount of payment for health care facilities reported a health insurance
recognized separately charged material provided in the reference period
in connection with the performances made during hospitalizations
reference period, except separately invoiced
material provided in the reference period in connection with the performances made during
hospitalizations in the reference period are included in the Classification
included in the enumerated categories listed in section 2


ZULPhosp total amount of payment for healthcare facilities through a health insurance
recognized separately charged Medicines
granted in the reference period in connection with the performances made during
hospitalizations during the reference period, except for specially
charged medicinal products granted in the reference period in connection with
performances made during hospitalizations in the reference period
are included in the Classification enumerated categories listed in section 2


LPhosp

Lump sum which is paid medicinal products pursuant to § 17 paragraph. 7
bill for days, treating declared a health insurance recognized as
reference period stretched for hospitalizations in the reference period, with the exception of medicinal
products provided in the reference period in connection with
performances made during hospitalizations in the reference period
which are included in the Classification
listed categories listed in section 2


KPhosp total amount of payment for other health care paid in Czech crowns
(except ZUMhosp, ZULPhosp and LPhosp) declared a health insurance
recognized as the reference period, provided medical facilities in
during hospitalizations reference period, except for health care
granted in the reference period in connection with the performance, made
hospitalizations during the reference period, which by the Classification
included in the enumerated categories listed in section 2


CMalfa2008 number of hospitalizations completed in the reference period are included in the Classification
grouped related to the diagnosis, multiplied
indices of these groups, which are listed in the Annex. 10


IZSalfa2008 individual base rate, which is calculated as follows:

IZSalfa2008 = [(* Valfaa ICBref) ZUMalfa + + + ZULPalfa LPalfa KPalfa +] / CMalfa2008
Where
:


Valfa total number of recognized medical facility and health insurance recognized
points over the reference period for procedures performed
hospitalizations during the reference period, which by the Classification
included in the groups listed in Annex no. 10; the number of points by the first sentence
converted at the current list of achievements 1.1.2009


ICBref calculated individual price point of medical devices specified in paragraph 3.1



ZUMalfa total amount of payment for health care facilities reported a health insurance
recognized separately charged material provided in the reference period
in connection with the performances made during hospitalizations
reference period, which by the Classification
assigned to groups listed in the Annex. 10


ZULPalfa total amount of payment for healthcare facilities through a health insurance
recognized separately charged Medicines
granted in the reference period in connection with the performances made during
hospitalizations during the reference period, which by
classification assigned to groups listed in the Annex. 10


LPalfa lump sum which is paid medicinal products pursuant to § 17 paragraph. 7
bill for days, treating declared a health insurance recognized as
reference period stretched for hospitalizations in the reference period, || | which, under the classification assigned to groups listed in the Annex. 10



KPalfa total amount of payment for other health care paid in Czech crowns
(except ZUMalfa, ZULPalfa and LPalfa) declared a health insurance
recognized as the reference period, provided medical facilities in
during hospitalizations reference period, which according
classification assigned to groups listed in the Annex. 10


Kn rate increase lump-sum reimbursement, which is fixing for 2009 in the amount of at least 1.05


3.2 In the event that the number of hospitalizations in 2009 grouped in
related to the diagnosis according to the classification listed in the Annex. 10, is in a medical facility
less than 200, not a deduction from
lump sum payments (PUhosp2008) under section 3.1 (a flat-rate component
payment for inpatient care (PUhosp2009) is calculated as PUhhosp2008 * Kn)
payment or in the form of case-based lump sum provided for in section 4.

3.3 Flat-rate component payment for inpatient care (PUhosp2009)
belong to the medical facility where medical equipment is recognized and
health insurer recognizes the number of hospitalizations completed in 2009
classified into groups related to the diagnosis by Classification , multiplied
Indices, which are listed in Annex no. 9
of at least 98% of health facilities and health insurer reported
recognized the number of hospitalizations, completed in 2008, included in the groups related to
diagnosis by classification, multiplied Indices
which are listed in Annex no. 9 as well as medical equipment
recognize and health insurance company recognizes the number of hospitalizations

Completed in 2009, included in the groups related to the diagnosis
by classification, which are listed in Annex no. 9
of at least 90% of health facilities and health insurer reported
recognized number of hospitalizations, completed in 2008, included in
groups related to the diagnosis according to the classification listed in the Annex.
9th Do not assessed the reference period are not counted
hospitalization, which are included in the Classification listed
groups and those listed in the Annex. 10.

3.4 If the medical facility declared and recognized by health insurance
number of hospitalizations, completed in 2009, included in
groups related to the diagnosis by classification, multiplied Indices
which are listed in Annex no. 9, will be less than 98%
medical device recognized and certified by health insurance
number of hospitalizations, completed in 2008, grouped in
related to the diagnosis by classification, multiplied by the indices, which are listed in Annex
. 9, or if the health facilities reported a health insurance
recognized hospitalizations completed in 2009
classified into groups related to the diagnosis of the Classification, which
listed in Annex no. 9, will be less than 90
% medical device recognized and certified by health insurance
number of hospitalizations, completed in 2008, grouped in
related to the diagnosis by classification, which are listed in Annex no. 9
lump sum payment for ingredient inpatient care (PUhosp2009) for the year 2009
reduced by such a number of percentage points, corresponding to the higher of the two
values, which has not reached 90%, or 98%, corresponding values ​​
under point 3.3. Do not assessed the reference period are counted
hospitalization, which are included in the Classification
listed groups and those listed in the Annex. 10.

3.5 Health insurance in 2009 will provide a contractual
medical facility in the aggregate coverage of health care included
according to 3.1. to (PUhosp2009) and health care shifted
Classification according to specified groups listed in item 2 of at least
corresponding to 107% reimbursement of such care in 2008.

Fourth Payment in the form of a case fee (PUdrg2009)
includes payment for health care is classified under classification into groups related to
diagnosis listed in the Annex. 10 and determined as follows:
PUdrg2009 - CMred * ZSalfa2009
Where
:

CMred CMalfa2009 reduced the amount of which is determined by the amount

CMalfa2009 with the following exceptions:

A) if the ratio CMalfa2009 / CMalfa2008 is greater than 1.15, then
CMred CMalfa2008 = 1.15 *

B) if the ratio CMalfa2009 / CMalfa2008 lie in the interval from 1.05 to 1.15
while, the PPalfa is smaller than 0.98, then
CMred CMalfa2009 = * (PPalfa + 0.02)
Where
:

PPalfa ratio of the number of recognized medical facility and health insurance
recognized hospitalizations, completed in 2009, included
into groups related to the diagnosis according to the classification listed in Annex
No. 10, and medical facilities
reported and health insurance recognized by the number of hospitalizations, completed in 2008,
classified into groups related to the diagnosis of the Classification, which
listed in the Annex. 10.


ZSalfa2009 base rate for payment of fee in the form of a case that for the year 2009
calculated as follows:
ZSalfa2009 = [IZSalfa2008 * (1 - Kp) + (Kp ZSref *)] * Knalfa || | Where
:


Kp coefficient approach that for 2009 fixed at 0.2


ZSref reference (national) base rate, which is determined in the amount of CZK 24,615



Knalfa increase coefficient ZSalfa2009 base rate fixed for 2009 at 1.05


Fifth Outpatient component of the settlement includes payment
specialized outpatient medical care, health care in specializations 603 and 604, according to the list
performances, health care physicians for adults and
practitioners for children and adolescents, health care provided | || dentists, health care in the listed specializations,
medical transport, emergency medical service and health care provided by
specializations 902, 911, 914, 921 and 925 (hereinafter referred to as "ambulatory care") with || | exception of the performances, which is recognized income and release testing.


5.1 for specialized outpatient health care, paid for by
list of operations, the value of the item and the amount of reimbursement of health care down
in Annex no. 3 hereto, with the exception of the performances 43311, 43313, 43315, || | 43613, 43617, 43627, 43629, 43633, according to the list of achievements for which
point value determined in the amount of CZK 0.71. For determining the amount of this
health care is not calculated volume for each
expertise and reduced the point value for the health care provided above this volume
which are listed in Annex no. 3 A), point 1. C).

5.2 for healthcare provided in 603 specialties and 604, according
list of achievements, paid for by the list of operations, the value of the item and the amount
reimbursement of health care provided in Annex no. 4 hereto.
For determining the amount of reimbursement of health care is not calculated volume
individual expertise and reduced the point value for health care
provided beyond this volume, which are listed in Annex no. 4 A) point 1
.

5.3 for health care provided by general practitioners and
practitioners for children and adolescents, paid a combined capitation payment
power, combined capacity- performance payment of capitation or by calling
list performances, a point value,
amount of reimbursement of healthcare provided in Annex no. 2 hereto.

5.4 Health care provided by dentists are paid according to § 7 of this Decree
.

5.5 for healthcare provided in specified specializations,
paid by the list of operations, the value of the item and the amount of coverage for health care
down in Annex no. 5 hereto.

5.6 For the performance of health services, funded by the list of operations, the
point value and the level of reimbursement of health care provided in Annex no. 8 of this Decree
.

5.7 Health care provided in the framework of an emergency medical service is paid
according to § 13 of this Decree.

5.8 for healthcare provided expertise in 902, according to the list
performance, paid for by the list of operations, the value of the item and the amount of reimbursement
healthcare provided in Annex no. 7 to this Decree.

5.9 for healthcare provided in specializations 911, 914, 921 and 925
list performances, paid for by the list of operations, the value of the item and
level of reimbursement of health care provided in Annex no. 6 to this Decree .

5.10 Reimbursement for health care as specified in paragraphs 5.1 to 5.9, provided
in 2009, recognized medical facilities to 31.3.2010 and health insurance
recognized to May 31, 2010 will be equal to the sum of payments calculated by
points from 5.1 to 5.9 in the case that the sum is not lower than 105%
value (Uamb2008) and at the same time will not exceed 109% of the value (Uamb2008).
Value (Uamb2008) is calculated as follows:
Uamb2008 = Vamb * ICBref ZUMamb + + + ZULPamb KPamb
Where
:


Vamb total number of recognized medical facility and health insurance recognized
points over the reference period for procedures performed in outpatient care
; the number of points the first sentence shall be converted at the current list of operations
1.1.2009


ICBref calculated individual price point of medical devices that
down in point 3.1.


ZUMamb total amount of payment for health care facilities reported a health insurance
recognized separately charged material provided in the reference period
in outpatient care


ZULPamb total amount of payment for healthcare facilities through a health insurance
recognized separately charged Medicines
granted in the reference period in outpatient care


KPamb total amount of payment for other health care paid in Czech crowns
(except ZUMamb and ZULPamb) declared a health insurance recognized as
reference period in outpatient care

The payment for health care as specified in paragraphs 5.1 to 5.9 is not included
health care, which has been in the reference period covered within
individually contracted remuneration component.

5.11 If sum payments calculated in accordance with paragraphs 5.1 to 5.9
will be less than 105% of the value (Uamb2008) provides the final payment (UVamb2009) as
:
UVamb2009 Uamb2008 = 1.05 *

5.12 If sum payments calculated in accordance with paragraphs 5.1 to 5.9
will be higher than 109% of the value (Uamb2008) provides the final payment (UVamb2009) as
:
UVamb2009 Uamb2008 = 1.09 *

5.13 As reported by medical facilities and health insurance

Recognized points for outpatient care in 2009 will be less than 100%
points reported by medical facilities and health insurance
recognized for services provided in outpatient care for
reference period, and in if the resulting reimbursement for outpatient care
will be determined in accordance with paragraphs 5.10 to 5.12, the resulting payment
(UVamb2009) for 2009, reduced by the same number of percentage points
which was not reached 100% of the value (Uamb2008 ) specified in section 5.10

6th If in a medical facility to changes in the scope and structure
reimbursed care provided in comparison with the reference period and
health insurance company will approve these changes, take them into account in the contract, including quantification
increase (reduction) payments.

7th Health insurance account the volume change through a health insurance company recognized
extremely costly healthcare provided in
2009 compared to 2008. Extremely expensive health care
For the purposes of this decree means healthcare provided medical facilities insured
whose volume exceeds the amount of CZK 1,000,000.
To the volume of health care are counted separately charged medicines, especially
charged material lump sum which is paid Medicines
according to § 17 para. 7 of the Act and the point value of medical procedures, according
list performance with a point value of 0,91 CZK. If
extremely costly care includes individually contracted
medicinal products, paid in 2009 for specialized workplaces according to §
15 paragraph. 7 point. b) of the Act, under Section 2 or health care paid
form of case-based lump sum referred to in point 4, the health insurance
account the difference between the calculated volume of health care provided
payment of health care. Do extraordinarily expensive care is not counted
health care under point 2, listed by classification into groups
related to the diagnosis 08021, 08022, 08023, 08041, 08042, 08043, 08181,
08182, 08183, 05011, 05012 , 05013, 05070, 05161, 05162, 05163, 05111,
05112, 05113, 02041, 02042, 02043, listed in Annex no. 9.

8th Do lump component reimbursement for inpatient care under point 3
does not include health care provided to insured persons from the EU.

9th For health care paid for by the list of operations, down
point value of 0,91 CZK.

B) Residential care under § 3 para. 2

First Flat rate per day of hospitalization

A) flat rate per day of hospitalization down for each category
patient and the type of treatment the day alone and includes the value
respective day of treatment, including the overhead associated with Curing
date and category of the patient, according to the list performances, a lump sum which is paid
medicinal products pursuant to § 17 para. 7 of the Act, and health procedures
which is recognized income and layoff list
examination performance.

B) The amount of the flat rate per day of hospitalization, except
psychiatric specialist medical institutions exhibiting treatment days
00021 and 00026 according to the list of performances is fixed at 107%
flat rate per treatment day belonging medical facility in 2008.

C) The flat rate per day of hospitalization in a psychiatric
specialized health care institutions exhibiting treatment days 00021 and 00026
list of performance shall be in the amount of 113% flat rate per treatment day
belonging medical devices 2008.

D) If the medical facility to changes in the scope and structure
reimbursed care provided in comparison with 2008 and health insurance
approve these changes, take them into account in the contract, including a quantification
increase (reduction ) payments.

Second Reimbursement of outpatient care, special outpatient care and special institutional care


A) for ambulatory health care paid for by the list of operations
point value determined in the amount of CZK 0.95.

B) For special outpatient care provided in accordance with § 22 letter. c)
bill paid by the list of operations, establishing a point value in the amount of CZK 0.90
.

C) For the special institutional care provided in health facilities
hospice type pursuant to § 22a of the Act, paid for by the list of performances is determined
point value in the amount of CZK 0.90.

C) Regulatory constraints

First If the total payment for medicines and medical devices

Prescribed medical facilities insured health insurance company
affiliation (hereinafter referred to as "competent health insurance company")
in 2009, except for medical devices approved revision
doctor, exceeds 105% reimbursement for medicines
products and medical devices prescribed in 2008, with the exception of medical devices approved
review doctor, a health insurance company in the overall
payment of medical devices to reduce the payment of an amount corresponding
more than 40% of the excess. In total remuneration also included
additional payments for medicines, for which the prescribing doctor ruled out the possibility of replacing
according to § 32 par. 2 of the Act.

Second In the event that medical facilities provided in the first half or in
second half of 2009, 100 health care and less relevant
insured health insurance, health insurance does not apply the regulation referred to in point 1

Appendix 2


Point value, the amount of reimbursement of health care and regulatory restrictions under § 4

A) Combined capacity- performance payment

First The amount of the capitation payment is calculated according to the number of insured converted
competent health insurance company, multiplied by the base rate set
per one registered insured by the respective insurance
per calendar month. The base rate under the first sentence shall be EUR

A) 50 CZK for physicians and general practitioners for children and adolescents,
who provide medical care to the extent of at least 30
office hours spread over 5 days per week, with at least one day a week
have extended opening hours to 18 hours, allowing
insured ordered at least two days a week for a fixed
hour

B) 49 CZK for physicians who provide medical care to the extent of at least 25
office hours spread over 5 days per week, with at least one
weekday office hours are extended until at least 18
hours. If local conditions require,
health insurance with medical facilities
agree to an extension of office hours differently.

C) 47 CZK for other practitioners,

D) 49 CZK for other practitioners for children and adolescents.

E) Number of insured converted by the respective insurance
is calculated by multiplying the number of registered healthcare facilities
insured by the respective insurance in the individual age groups
according to item 7, index multiplied by paragraph 7 above basic
rate, or the total amount of remuneration may be increased subject
conditions laid down in the contract between health insurers and health facilities
.

Second Performances by the list of operations included in capitation payments expertise
001, according to the list of achievements:
----------- ----------------- -------------------------------------------------- ---------
no. This performance
----------- --------------------------------
01023 -------------------------------------------- targeted testing GPs
01024 CONTROL seen by a GP
01025 CONSULTATION practitioner FAMILY MEMBERS OF PATIENT
01030 Administrative tasks practitioner
04,508 local treatment of gingival / mucosal 09,215
im injection, SC, ID
09,216 injections into the soft tissue or intradermal buds WITHIN REFLEXNÍLÉČBY
09,217 INTRAVENOUS INJECTION an infant or child up to 10 years
09,219 INTRAVENOUS INJECTION an adult or child OVER 10 YEARS 09,220
peripheral vein cannulation INCLUDING THE INFUSION
09233 FILLED precinct anesthesia
TREATMENT 09,237 and bandaging wounds from 1 cm2 to 10 cm2
09,241 outweigh AND TREATMENT WOUNDS FROM 10 TO 30 CM2 CM2 09,507
SUPPORT PSYCHOTHERAPY by physicians NEPSYCHIATREM 09,511
minimal contact between doctor and patient | || 09,513 telephone consultations attending physician PATIENT EDUCATION INTERVIEW
09,523 doctors with patients or families
09525 INTERVIEW WITH FAMILY MEDICAL TREATMENT
44,239 and prevalence of leg ulcer Physicians (1 BEREC)
71511 REMOVING foreign bodies from the ear
71,611 EXCLUSION foreign bodies from the nose - SIMPLE
----------- ------------------------- -------------------------------------------------- -

Third Performances by the list of operations included in capitation payments expertise
002, according to the list of achievements:

----------- ------------------------------------ ----------------------------------------
No. name

Performance ----------- ----------------------------------- -----------------------------------------
01025 CONSULTATION practitioner FAMILY MEMBERS OF PATIENT
01030 Administrative tasks practitioner
02023 targeted examination by general practitioners for children and youth - children under 6 years
02024 Control examination by general practitioners for children and youth - children under 6 years
02,033 targeted examination by general practitioners for children and youth - CHILD OVER 6 YEARS
02034 Control examination by general practitioners for children and youth - CHILD OVER 6 YEARS
04,508 local treatment of the gingiva / mucosa
06111 COMPLEX - Examination of the patient's condition SISTER own social environment
06119 COMPLEX - samples of biological material
06121 COMPLEX - local treatment
06123 COMPLEX - Education, reeducation, NURSING REHABILITATION
06125 COMPLEX - enemas, douches, catheterization, irrigation, treatment of indwelling catheters
06127 COMPLEX - administration of inhalation and healing therapies PO, S. C, IM, IV, UV,
EVENT.DALŠÍ APPLICATIONS
06129 for training and mentoring inject insulin
09215 INJECTION IM, SC, ID
09,216 injections into the soft tissue or intradermal buds WITHIN reflexology treatments
09217 INTRAVENOUS INJECTION an infant or child up to 10 years
09219 INTRAVENOUS INJECTION an adult or child OVER 10 YEARS
09220 cannulation of peripheral veins INCLUDING THE INFUSION
09,221 infusion in infants or children under 10 years
09233 FILLED precinct anesthesia
09235 removal of small skin lesions
09237 outweigh TREATMENT AND WOUNDS FROM 1 TO 10 CM2 CM2
09241 outweigh TREATMENT AND WOUNDS 10 CM2 - 30 CM2
09253 PREPUCIA RELEASE, INCLUDING non-surgical repositioning Paraphimosis
09507 SUPPORTIVE PSYCHOTHERAPY by physicians NEPSYCHIATREM
09511 minimal contact between doctors and patients
09,513 telephone consultations attending physician PATIENT
09523 MEDICAL EDUCATION INTERVIEW with the patient or family
09525 INTERVIEW WITH FAMILY PHYSICIAN
71511 REMOVING foreign body from the ear
71,611 EXCLUSION foreign body from the nose - SIMPLE
----------- ---------------------------- ------------------------------------------------ || |
Fourth For medical services not included in capitation payments, medical
performances unregistered insured under the health insurance company and the insured
EU health facilities through a health insurance
recognized, funded by the list of operations, establishing a value
point in the amount of CZK 1.05.

Fifth For performances 01021.01022, 02021, 02022, 02031, 02032, 02110 and 02120,
list performances down the point value of 1.10 CZK.

6th For the performance of traffic visiting service, funded by the list of performances
down point value of 0,91 CZK.

7th The index is the ratio of costs to insured persons in that age group
towards the cost of the insured in the age group 15-19 years.

Age groups and indexes:
--------------------------

Age group -------------------------- Index

0-4 years 3.80
5-9 years 1.65
10-14 years
1.30 15 - 19 1.00
20-24 years
0.90 25-29 years 0.95
30-34 years 1.00
35-39 years
1.05 40-44 years 1.05
45-49 years
1.10 50-54 years 1.35
55-59 years
1.45 60-64 1.50
65-69 years
1.70 70-74 years 2.00
75-79 years 2.40
80-84 years
2.90 85 and over 3.40 --------------------------


B) Combined capacity- performance payment of capitation by calling

First The amount of the capitation payment by calling the capitation is determined under subparagraph
A) point 1. Calling capitation is granted in cases where practical
doctor or a general practitioner for children and adolescents has, with regard to
geographic conditions, smaller number of adjusted insured
registered with the health insurance company than the 70% national average
number of those insured (national average
number is always determined for the calendar year, according to data of the Central registry
insured, managed by General health
insurance Czech Republic) and the provision of such care is necessary to fulfill the obligations
health insurance according to § 46 para. 1 of the Act.

Second Match capitation can provide up to 90% capitation payments
calculated nationwide average number of adjusted insured

Registered with the competent health insurance company. On Match participates
health insurance company with which the medical device
concluded a contract for the provision and payment of healthcare share corresponding
percent of their insured the restatement registered
insured by health facilities.

Third To cover the performance list with the performance point. A) points 4-6
apply mutatis mutandis.

C) Health care covered by the list of operations

For health care paid for by the list of performances down
point value of CZK 1; Transport for performances in guest service provides
point value of 0,91 CZK.

D) Regulatory constraints

First Regulation on prescribed medicines and medical devices and to pull
care in listed specializations (in the requested care
exclude medical procedures mammography screening carried
medical device that has a health insurance company to provide these health
performance of an existing contract)

01.01 If the average reimbursement for medicines and medical devices
prescribed medical facilities, relative to one
converted insured exceeds by more than 20% of the national average
pay for prescribed medicines and medical devices, health insurance is
entitled to exercise control deduction to 25% of
exceeded. To the average payment per insured converted to
will also include additional payments for medicines, for which the prescribing doctor
ruled out the possibility of replacing according to § 32 par. 2 of the Act and that
health insurance paid.

02.01 If the average payment for solicited care in the listed
specializations, according to the list of operations, related to one full-time equivalent
insured exceeds by more than 20% of the national average payment per
solicited care in the listed specializations, the health insurance
entitled to exercise control deduction to 25% of the excess.

Second Regulatory restrictions of paragraph 1.1 and 1.2 do not apply if
medical devices justify the health care provided on the basis of which
exceeding the average reimbursement under Section 1.1, or
02.01

Third Regulatory restrictions of paragraph 1.1 and 1.2 also apply if
medical facility in 2008 or 2009 registered 50 and less relevant
insured health insurance or medical care provided
50 and less unregistered insured by the respective insurance || | or in the case of health care provided to insured persons from the EU.

Fourth Regulatory restrictions under Section 1.1 shall not apply if the total payment
for all medicinal products and medical devices
prescribed by GPs and GPs for children and adolescents in 2009
will not exceed the estimated amount of reimbursement for this type of health care
year 2009 based on the health insurance plan
competent health insurance company.

Fifth Regulatory restrictions under section 1.2 shall not apply if the total payment
for solicited care in the specializations listed in 2009
will not exceed the estimated amount of reimbursement for this kind of healthcare for 2009
based on the health insurance plan appropriate health || | insurer.

6th The health insurance company is entitled to exercise control deduction by
points 1.1 and 1.2 up to a maximum amount corresponding to 15% of the volume of reimbursement
provided by the health insurance fund medical equipment for
capitation payment and medical services reduced by the amount of reimbursement for extra
charged material and separately charged Medicines for 2009.
Appendix 3


Point value, the amount of reimbursement and regulatory restrictions under § 5

A) The point and the level of reimbursement

First The amount of payment is determined by a list of performance payment for medical services rendered
a point value equal

A) CZK 1.08 to healthcare facilities providing hemodialysis care
for healthcare facilities reporting 910 performances expertise -
psychotherapy list of performance together with curative day care centers daily
list performances

B) CZK 1.08 for medical devices contracting expertise 901 -
clinical psychology, CZK 0.75 for medical devices contracting expertise 903 -
clinical speech therapy and CZK 1 for healthcare facilities contracting expertise

927 - orthoptist, according to the list of operations,

C) CZK 0.71 for performances 43311, 43313, 43315, 43613, 43617, 43627, 43629, 43633
, according to the list of operations, contractual expertise 403 -
radiation oncology, according to the list of performances, || |
D) CZK 1 for other medical facilities to the volume calculated for each
expertise, according to the list of operations, as follows:


POPho
PBro x --------
grapple

Where
:


PBro total number of recognized medical facility and health insurance recognized
points over the reference period. The reference period is the appropriate means
half of 2008.


POPho number of unique insured treated in medical facilities
reporting period. The evaluation period means the respective half
, 2009. Unique policyholder means one insured
competent health insurance company treated by health facilities in the specialty
under review or reference period at least once, while
does not matter whether it is a treatment within their own care or the care
solicited. If this insured health facilities in the
expertise treated in the corresponding half times, to include the number of unique
insured the health insurance company, and treated in the
expertise only once.


Grapple number of unique insured treated at the medical facility
expertise in the reference period

Health care provided health care facility over the calculated volume
in the specialty, expressed in number of points for the performance of a medical device
declared a health insurance company recognized for the reference period shall be paid
list of performances with a point value equal to CZK 0.30.

For medical devices that exist in the reference period, or
which did not provide care in the specialty, may
health insurance for the purpose of calculating the volume, average number of points per
one unique insured treated in the specialty
for the reference period, comparable medical facilities.

In the medical facility, where compared to the reference period will be due to changes
contracted scope of health care provided in some
expertise (ie. Changing spectrum of contracted power)
increase in the average number of points per unique insured, the volume of
points, according to point 1. d) increase the number of points that corresponds
medical facility declared and recognized by health insurance
newly contracted health interventions.

Decreased point in the specialty according to paragraph 1 shall not apply:

A) in the case of medical devices, which reference or
period under review within one expertise were treated with 100 or fewer unique
insured, while the contracted value of the relative numbers of capacitive
1.00. In the case of capacitive relative number less than 1.00
a limit of 100 unique treated insured contracted
recalculates the value of the capacitive relative numbers for the specialist.
Capacitance proportional number expresses the size of the contracted value
range of health care for the expertise provided by one carrier of performance
a health insurance company,

B) in the case of health care provided to insured persons from the EU.

In the cases I referred to in point. a) and b) are all paid with performances
point value referred to in point 1. d).

B) Regulatory constraints

First Provided that a medical device reaches the average payment per
unique insured for separately billed drugs (with the exception
charged separately medicines reimbursed for specialized
work in accordance with § 15 para. 7 font. B) of the Act), and separately charged
material in the reporting period greater than 110% of the average payment per
unique insured for separately billed drugs (except
charged separately medicines reimbursed for specialized
work in accordance with § 15 para. 7 point. b) of the Act), and separately charged
material in the reference period, the health insurance company may
medical devices after 2009, to reduce payment of an amount corresponding to 40%
increased costs for separately billed medicines and especially || | charged material (over 110%), and methods contained in the contract
medical facilities and health insurance companies.


Second If the medical device reaches the average payment per insured
unique for prescribed medicines and medical devices
period under review, higher than 105% of the average payment per
one unique insured for prescription medicines and medical devices
reference period, the health insurance company may
medical facility after the end of 2009, reduce the payment of an amount corresponding to 40%
increased cost of prescribed medicines and medical devices
(over 105%), and methods contained in contract
medical facilities and health insurance companies. To the average payment per
one unique insured will also include supplemental payments for medical
products for which the prescribing doctor ruled out the possibility of replacing
according to § 32 par. 2 of the Act.

Third If the medical device reaches the average payment per insured
unique for solicited care in the specializations listed in
reporting period exceeds 110% of the average payment per unique
insured in the reference period, the health insurance company may
medical devices after the end of 2009, reduce the payment of an amount corresponding to 40%
increased costs for requested care (over 110%), and
methods contained in the contract of medical facilities and health insurance
. Do not include the requested care medical services
screening mammography and cervical cancer screening
by a health care facility, which has a health insurance company to
providing these medical procedures concluded a contract.
For the purposes of determining the amount of the average payments and the amount of any reduction, according to the sentence
first performances are solicited care in the reporting period and the reference appreciate
list performances in force 1.1.2009 point value in force at the reporting
period.

Fourth Regulatory restrictions of paragraph 1 to 3 shall not apply if the medical device
reasons provided health care, giving rise to
exceeded the average payments in accordance with point 1 of Section 2 or Section 3 by
|| |
Fifth Regulatory restrictions of paragraph 1 shall not apply if the total zhrada
for all separately billed medicines and separately charged material
outpatient healthcare facilities providing outpatient
specialized care in 2009 will not exceed by the relevant health insurance 106
% reimbursement for this type of health care in 2008.

6th Regulatory restrictions of paragraph 2 shall not apply if the total payment for
all medicinal products and medical devices
prescribed in outpatient healthcare facilities providing outpatient
specialized care in 2009 will not exceed the estimated amount of reimbursement for this type of medical
care for 2009 based on the health insurance plan
competent health insurance company.

7th In the medical facility, where compared to the reference period there was a change of the contracted
range of health care provided (change of performances
carriers authorized to prescribe medicinal products and medical devices
and require care in specializations listed
), health insurance By agreement with the medical device
, the average value of payments in the reference period for these purposes
proportionately adjusted.

8th For medical devices, which in the reference period or in its
part did not exist or had a contract with the health
insurance, health insurance can be used for the purpose of applying
regulatory restrictions in points 1-3 benchmarks comparable || | medical equipment.

9th If the medical facility were treated or assessed in reference
period in the specialty 50 or fewer unique policyholders, while
contracted value of capacitance proportional numbers 1,00, health insurance
this profession are excluded from the calculation of regulation under points 1 to
third In the case of capacitive relative number less than 1.00, the limit of 50
unique treated insured converted contracted value
capacitive relative numbers for the specialist.

10th Regulatory restrictions of paragraph 3 shall not apply if the total payment
for solicited care in the specializations listed in 2009
will not exceed the estimated amount of reimbursement for this kind of healthcare for 2009

Based on the health insurance plan
competent health insurance company.

11th The health insurance company is entitled to exercise control points deduction by
1-3 maximum amount corresponding to 15% of the volume of reimbursement
provided by the health insurance fund medical equipment for
medical services less the amount of reimbursement for separately charged material and
separately charged Medicines for 2009.

12th If the medical facility prescribes medical device
over CZK 15 000, approved by the review doctor health insurance, it will not
amount is included in regulatory constraints.

13th Health insurance may provide medical equipment
monthly pre-payment of one-sixth volume of 106% reimbursement for
corresponding reference period, or in the amount of medical equipment
reported or recognized health insurance
health care in the given month . The chosen form of interim payments
maintain health insurance after the trial period, if
medical facilities during the reporting period, requests for reduction of the preliminary
payments. Preliminary settlement period under review will be financially settled
within the overall financial settlement, including regulatory limitations,
no later than 120 days after the end of the reporting period.
Appendix 4


Point value, the amount of reimbursement and regulatory restrictions in accordance with § 6

A) The point and the level of reimbursement

The level of compensation is determined by a list of performance payment for medical services rendered
with a point value of CZK 1, in volume computed
individual expertise, as follows:


POPho
PBro x ---------
grapple


Where
:


PBro total number of recognized medical facility and health insurance recognized
points over the reference period. The reference period is the year 2008.



POPho number of unique insured treated in medical facilities
reporting period. The evaluation period is the year 2009.


Grapple number of unique insured treated at the medical facility
expertise in the reference period

Health care provided health care facility over the calculated volume
in the specialty, expressed in number of points for the performance of a medical device
declared a health insurance company recognized for the reference period shall be paid
list of performances with a point value equal to CZK 0.30.

For medical devices that exist in the reference period, or
which did not provide care in the specialty, may
health insurance for the purpose of calculating the volume, average number of points per
one unique insured treated in the specialty
for the reference period, comparable medical facilities.

In the medical facility, where compared to the reference period will be due to changes
contracted scope of health care provided in some
expertise (ie. Changing spectrum of contracted power)
increase in the average number of points per unique insured, the volume
number of points by 1 point increase on the number of points that corresponds to a medical facility
declared a health insurance company recognized a newly contracted
health interventions.

Decreased point in the specialty according to paragraph 1 shall not apply:

A) in the case of medical devices, which reference or
period under review within one expertise were treated with 100 or fewer unique
insured, while the contracted value of the relative numbers of capacitive
1.00. In the case of capacitive relative number less than 1.00
a limit of 100 unique treated insured contracted
recalculates the value of the capacitive relative numbers for the specialist.
Capacitance proportional number expresses the size of the contracted value
range of health care for the expertise provided by one carrier of performance
a health insurance company,

B) in the case of health care provided to insured persons from the EU.
In the cases they referred to in point. a) and b) all services paid with the value points
mentioned in point 1

B) Regulatory constraints

First If the medical device reaches the average payment per
unique insured for separately billed drugs (except
charged separately medicines reimbursed for specialist

Work in accordance with § 15 para. 7 point. b) of the Act), and separately charged
material in the reporting period greater than 110% of the average payment per
unique insured for separately billed drugs (except
charged separately medicines reimbursed at specialized workplaces according
§ 15 para. 7 point. b) of the Act), and separately charged
material in the reference period, the health insurance company may
medical devices after 2009, to reduce payment of an amount corresponding to 40%
increased costs for separately Medicines charged and billed separately
material (over 110%), and methods contained in the contract
medical facilities and health insurance companies.

Second If the medical device reaches the average payment per insured
unique for prescribed medicines and medical devices
period under review, higher than 105% of the average payment per
one unique insured for prescription medicines and medical devices
in the reference period, the health insurance company may
medical facility after the end of 2009, reduce the payment of an amount corresponding to 40%
increased costs for prescription medicines and medical devices
(over 105%), and methods contained contract
medical facilities and health insurance companies. To the average payment per
one unique insured will also include supplemental payments for medical
products for which the prescribing doctor ruled out the possibility of replacing
according to § 32 par. 2 of the Act.

Third If the medical device reaches the average payment per insured
unique for solicited care in the specializations listed in
reporting period exceeds 110% of the average payment per unique
insured in the reference period, the health insurance company may
medical devices after the end of 2009, reduce the payment of an amount corresponding to 40%
increased costs for requested care (over 110%), and
methods contained in the contract of medical facilities and health insurance
. Do not include the requested care medical services
screening mammography and cervical cancer screening
by a health care facility, which has a health insurance company to
providing these medical procedures concluded a contract.
For the purposes of determining the amount of the average payments and the amount of any reduction, according to the sentence
first performances are solicited care in the reporting period and the reference appreciate
list performances in force 1.1.2009 point value in force at the reporting
period.

Fourth Regulatory restrictions of paragraph 1 to 3 shall not apply if the medical device
reasons provided health care, giving rise to
exceeded the average payments in accordance with point 1 of Section 2 or Section 3 by
|| |
Fifth Regulatory restrictions of paragraph 1 shall not apply if the total payment for all separately charged
medicines and separately charged material
outpatient healthcare facilities providing outpatient
specialized care in 2009 will not exceed by the relevant health insurance 106
% reimbursement for this type of health care in 2008.

6th Regulatory restrictions of paragraph 2 shall not apply if the total payment for
all medicinal products and medical devices
prescribed in outpatient healthcare facilities providing outpatient
specialized care in 2009 will not exceed the estimated amount of reimbursement for this type of medical
care for 2009 based on the health insurance plan
competent health insurance company.

7th In the medical facility, where compared to the reference period there was a change of the contracted
range of health care provided (change of performances
carriers authorized to prescribe medicinal products and medical devices
and require care in specializations listed
), health insurance in agreement with the medical device
average value of payments in the reference period for these purposes
proportionately adjusted.

8th For medical devices, which in the reference period or in its
part did not exist or had a contract with the health
insurance, health insurance can be used for the purpose of applying
regulatory restrictions in points 1-3 benchmarks comparable || | medical equipment.


9th If it was treated in a medical facility or a reference in the reporting period
in the specialty 50 or fewer unique policyholders, while
contracted value of capacitance proportional numbers 1,00, health insurance
this profession are excluded from the calculation of regulation under points 1 to
third In the case of capacitive relative number less than 1.00, the limit of 50
unique treated insured converted contracted value
capacitive relative numbers for the specialist.

10th Regulatory restrictions of paragraph 3 shall not apply if the total payment
for solicited care in the specializations listed in 2009
will not exceed the estimated amount of reimbursement for this kind of healthcare for 2009
based on the health insurance plan appropriate health || | insurer.

11th The health insurance company is entitled to exercise control points deduction by
1-3 maximum amount corresponding to 15% of the volume of reimbursement
provided by the health insurance fund medical equipment for
medical services less the amount of reimbursement for separately charged material and
separately charged Medicines for 2009.

12th If the medical facility prescribes medical device
over CZK 15 000, approved by the review doctor health insurance, it will not
amount is included in regulatory constraints.

13th Health insurance may provide medical equipment
monthly pre-payment of one-twelfth of 106% of the payment
for the corresponding reference period, or in the amount of medical equipment
reported or recognized health insurance
health care in the given month . The chosen form of interim payments
maintain health insurance after the trial period, if
medical facilities during the reporting period, requests for reduction of the preliminary
payments. Preliminary payment for the semester will be evaluated financially settled
within an overall financial settlement, including regulatory constraints and
no later than 120 days after the end of the reporting period.
Appendix 5


Point value and the level of reimbursement pursuant to § 8

First For the contracted performance of mammography screening, according to the list
performances down the point value of 1.10 CZK.

Second Contracted for performances cervical screening, according to the list
performances down the value of the item in the amount of CZK 1.03.

Third For healthcare provided expertise 809 list
performances, with the exception of powers set out in paragraph 6, to the amount calculated pursuant to paragraph 8
provides point value of 1.10 CZK.

Fourth For health care provided in specialized fields 807, 816, 817 and 823, according
list of operations, to the amount calculated pursuant to paragraph 8 states
point value in the amount of CZK 0.70.

Fifth For health care provided in specializations 222, 801, 802, 804
805, 812-815, 818, 819 and 822, according to the list of operations, to the volume
calculated according to section 8 provides point value of 0, 88 CZK.

6th Contracted for performances 89711-89725 and 89611-89619 performances, performances
list, down point value in the amount of CZK 0.80.

7th For health care provided to insured persons from the EU down the value
point under points 1 to 6

8th Health care provided in the corresponding half of 2009
listed specializations are to be paid with the value of a point by point 3-5
volume of 100% medical facility declared a health insurance company recognized
points for the corresponding half of 2008;
over the volume of health care paid to the value of CZK 0.45 points.

9th For medical devices, which in the corresponding half of 2009
exist, or that did not provide care in the specialty or who can not be
total payment volume determination can
health insurance for the purpose of calculating the amount under point 8 use an average || | payment per unique insured for the corresponding half of 2008
comparable medical facilities.

10th The provisions of paragraph 8 shall not apply if the medical facility
provided medical care 50 or less unique to the insured.
Provisions of paragraph 8 shall also apply in the case of health care provided to insured
EU.
Annex 6


Point value and the level of reimbursement pursuant to § 9

First For outpatient healthcare facilities providing health care expertise
925 down point value of CZK 1.


Second For outpatient healthcare facilities providing health care expertise
911 down point value in the amount of CZK 0.90.

Third For outpatient healthcare facilities providing health care in specialties
921 and 914 down the value of the item in the amount of CZK 0.90.

Fourth For the performance of traffic visiting service, funded by the list of performances
down point value of 0,91 CZK. At these performances are not covered
provisions in paragraphs 5 and 6

Fifth Health care provided health care facility to 110%
calculated volume, or adjusted according to section 7, shall be borne by
list of performances with a point value according to points 1 to 3
This volume is calculated as follows:


POPho
PBro x ----------
grapple
Where
:


PBro total number of recognized medical facility and health insurance recognized
points for the reference period, converted by
list of valid performances 1.1.2009. The reference period is the corresponding half of 2008.



POPho total number of unique insured treated
medical facilities during the review period. The evaluation period means the corresponding half of 2009



Grapple total number of unique insured treated medical facility in the reference period


6th Health care provided to medical facilities in the expertise of over 925
110% of the amount calculated in accordance with paragraph 5, or modified by
point 7 shall be met with the point value of 0,85 CZK, the expertise of 911
point value in the amount of CZK 0.75 and specializations 914 and 921 with a value
point in the amount of CZK 0.70.

7th If in a medical facility to changes in the scope and structure
reimbursed care provided in comparison with 2008 and health insurance
approve these changes, take them into account in the contract, including a quantification
increase (reduction) payments.

8th The provisions of paragraphs 5 and 6 shall not apply if the medical device
were treated with 50 or fewer unique insured in the reference period.

9th The health insurance company can arrange a medical facility
monthly pre-payment in the amount of health care facilities through a health insurance
recognized health care for the current month, while
this form of health insurance preserves throughout the respective half.
Preliminary payment for the corresponding half of the health insurance company financially
settle no later than 120 days after the end of the reporting period.
Annex 7


Point value and the level of reimbursement pursuant to § 10

First The point value is determined in the amount of CZK 0.80.

Second For the performance of traffic visiting service, funded by the list of operations,
the point value determined in the amount of CZK 0.91. At these performances are not covered by the provisions of Section 3


Third Health care provided health care facility above calculated
volume, or adjusted according to section 4 shall be paid according to the list of performances with
point value of 0,50 CZK. This volume is calculated as follows:


POPho
PBro x ---------
grapple



PBro total number of recognized medical facility and health insurance recognized
points for the reference period, converted by
list of valid performances 1.1.2009. The reference period is the corresponding half of 2008.



POPho total number of unique insured treated
medical facilities during the review period. The evaluation period means the corresponding half of 2009



Grapple total number of unique insured treated medical facility in the reference period


Fourth If in a medical facility to changes in the scope and structure
reimbursed care provided in comparison with 2008 and health insurance
approve these changes, take them into account in the contract, including a quantification
increase (reduction) payments.

Fifth The provisions of paragraph 3 shall not apply if the medical facility were treated
50 or fewer unique insured in the reference period.

6th If the average score reported by medical facilities and health insurance
recognized on one unique insured for
evaluation period is at least 98% of the average number of points per
unique insured for the reference period, while the average payment per
unique insured during the reporting period provided
medical equipment health insurance is less than 103%

Average payment per unique insured in the reference period
health insurance within the financial settlement
medical devices will increase the average payment per unique
insured for 103% of the average payment per unique insured in reference || | period.

7th If the average score reported by medical facilities and health insurance
recognized on one unique insured for
evaluation period reaches at least 98% of the average number of points per
one unique insured for the reference period
health insurance company in the financial settlement healthcare facilities reduce
average payment per unique insured
about the same number of percentage points which was not reached 98% of the amount specified in the first sentence
.

8th To calculate the average number of points per unique
insured under points 6 and 7 are also rated for the reference period, the list of achievements
valid on January 1, 2009.

9th The health insurance company can arrange a medical facility
monthly pre-payment either in the amount of medical facilities recognized, and
recognized health insurance, health care for a given month or
equal to one-sixth of 103% of the payments in the reference period while
chosen form of health insurance preserves throughout the respective half.
Preliminary payment for the corresponding half of the health insurance company financially
settle no later than 120 days after the end of the reporting period.
Appendix 8


Point value and the level of reimbursement pursuant to § 12

First The point value is determined

A) in the amount of CZK 0.95 to healthcare facilities providing health care
in continuous operation,

B) in the amount of CZK 0.90 for medical facilities that do not provide health care
in continuous operation.

Second Health care provided health care facility to 104% of the calculated volume
shall be paid according to the list of performances with a point value
set out in paragraph 1. This volume is calculated as follows:

POPho
PBro x -------
grapple

Where
:


PBro total number of recognized medical facility and health insurance recognized
points over the reference period. The reference period is the year 2008.



POPho total number of unique insured, which was the period under review
provided medical transport. The evaluation period is the year 2009.


Grapple total number of unique insured persons who have been in the reference period provided health
right

Third Above 104% of the amount calculated in accordance with paragraph 2 of the Health Insurance
entitled to adjust the value of the point referred to in paragraph 1, for
medical devices mentioned in point 1. a) to CZK 0.90 and
for medical devices mentioned in point 1 point. b) to CZK 0.80.

Fourth The provisions of paragraph 3 shall not apply to medical devices which
reference or evaluation period provided medical care less than 50
unique insured competent health insurance company.

Fifth Health insurance may provide medical equipment for 1st and
second half of 2009, pre-payment in the amount of 103% of the payment in the corresponding half of 2008.

Appendix 9


Groups related to diagnosis by Klasifikace5) with indices of these groups ------------------------- --------
-------------------------------------------------- ------------------------ ---------------
IR-DRG-5) group name index
-------- -------------------------------------- -------------------------------------------------- ----------- ---------------
00011 TRANSPLANTATION heart and / or lungs with no CC 23.0724 00012
heart transplant AND / OR LUNG S CC 32.6163
00013 TRANSPLANTATION heart and / or lung with MCC
00021 32.6163 liver transplant WITHOUT CC 17.2535 00022
liver transplant S CC 19.9298 00023
liver transplant S MCC 00031 34.9535
bone marrow transplant WITHOUT CC 13.5347
00032 bone marrow transplant S CC 13.5347
00033 bone marrow transplant with MCC 19.0624
00041 LONG mechanical ventilation for> 240 hours (11-21 days) without CC 12.4015
00042 LONG mechanical ventilation for> 240 hours (11 to 21 days) with CC 13.2383
00043 LONG mechanical ventilation for> 240 hours (11-21 DAYS) SMCC 15 , 5852

00051 LONG mechanical ventilation for> 96 h (5-10 days) without CC 6.4609
00052 LONG mechanical ventilation for> 96 h (5-10 days) with CC 6.4609
00053 LONG mechanical ventilation> 96 HOURS (5-10 days) with MCC 8.1370
00060 LONG mechanical ventilation for> 1800 hours (over 75 days) 78.5330
00070 LONG mechanical ventilation for> 1,008 hours (more than 43 days) with tRANSPLANTATION heart, lung, liver, 45.0340
BONE MARROW
00080 LONG mechanical ventilation for> 1008 hour (43-75 days) with EKONOMICKYNÁROČNÝM PERFORMANCE 45.0340
00090 LONG mechanical ventilation for> 1008 hour (43-75 DAYS) 42.5516
00100 LONG mechanical ventilation > 504 hours (22-42 days) with ECO POWER ROUGH 33.4824
00110 LONG mechanical ventilation for> 504 hours (22-42 DAYS) 24.9686
00121 LONG mechanical ventilation for> 240 hours (11-21 DAYS ) with economic performance without ROUGH CC 19.1562
00122 LONG mechanical ventilation for> 240 hours (11 to 21 days) with ECO POWER WITH ROUGH CC 19.1562
00123 LONG mechanical ventilation for> 240 hours (11-21 DAYS ) with economic ROUGH WITH POWER MCC 20.1382
00131 LONG mechanical ventilation for> 96 h (5-10 days) with economic performance without ROUGH CC 11.2003
00132 LONG mechanical ventilation for> 96 h (5-10 DAYS ) with economic ROUGH WITH POWER CC 11.2003
00133 LONG mechanical ventilation for> 96 h (5-10 days) with ECO POWER WITH ROUGH MCC 12.8137
01011 craniotomy WITHOUT CC 3.9413
01012 craniotomy With CC 5.3309
01013 craniotomy with MCC 7.6234
01021 spinal performance without CC 2.9806
01022 spinal exercising with CC 5.1765
01023 spinal exercising with MCC 6.2321 || | 01031 performance on extracranial arteries WITHOUT CC 2.5868
01032 performance on extracranial arteries with CC 2.9922
01033 performance on extracranial arteries with MCC 3.6285 01,041
performance on cranial and peripheral nerves WITHOUT CC 0 , 4207
01042 performance on cranial and peripheral nerves S CC 0.5032
01043 performance on cranial and peripheral nerves with MCC 0.8539
01051 RELEASE carpal tunnel WITHOUT CC 0.1469
01052 RELEASE CARPAL TUNNEL WITH CC 0.1989
01053 RELEASE Carpal Tunnel With MCC 0.1989
01061 Other feats during illness and nervous system disorders WITHOUT CC 1.2929
01,062 other performances during illness and nervous system disorders S CC 2 , 0807
01,063 other performances during illness and nervous system disorders with MCC 3.7345
01301 TROUBLES AND SPINAL CORD INJURY WITHOUT CC 0.6009
01302 TROUBLES AND SPINAL CORD INJURY WITH CC 0.8507
01303 DISORDERS A spinal cord injury with MCC 1.3467
01311 malignant diseases, some infections and degenerative disorders NERVOVÉHOSYSTÉMU WITHOUT CC 0.7338
01312 Nervous System disorders With CC 0.8158
01313 malignant diseases, some infections and degenerative disorders NERVOVÉHOSYSTÉMU With MCC 1.1369
01,321 multiple sclerosis and cerebellar ataxia WITHOUT CC 0.3448
01322 multiple sclerosis and cerebellar ataxia CC 0.4731
01323 multiple sclerosis and cerebellar ataxia MCC 0.8151 || | 01331 nontraumatic intracranial hemorrhage WITHOUT CC 1.1390 ​​
01332 nontraumatic intracranial hemorrhage S CC 1.4745
01,333 nontraumatic intracranial hemorrhage with MCC 2.5498
01341 of stroke Myocardial WITHOUT CC 0.8623 || | 01342 of stroke with myocardial infarction and CC 0.9839
01,343 of stroke with myocardial infarction and MCC 1.4916
01351 nonspecific stroke and precerebral OCCLUSION WITHOUT MYOCARDIAL WITHOUT CC 0.6841
01352 nonspecific VASCULAR precerebral stroke and heart attack with OCCLUSION WITHOUT CC 0.7719
01353 nonspecific stroke and precerebral OCCLUSION WITHOUT heart attack with MCC 1.1239
01361 TIA WITHOUT CC 0.4920
01362 TIA S CC 0.5690
01,363 transient ischemic attack with MCC 0.7237

01,371 DISORDERS cranial and peripheral nerves WITHOUT CC 0.5839
01372 DISORDERS cranial and peripheral nerves S CC 0.6664
01,373 DISORDERS cranial and peripheral nerves with MCC
.7606 01,381 bacterial and tuberculous infection NERVOUS SYSTEM WITHOUT CC 2.5426
01382 bacterial and tuberculous infection nervous system CC 2.5426
01,383 bacterial and tuberculous infection nervous system MCC 7.2450
01,391 nonbacterial infections, NERVOUS SYSTEM, OTHER THAN viral meningitis BEZCC 0.7866
01,392 nonbacterial infections, NERVOUS SYSTEM, EXCEPT viral meningitis S CC 1.1022
01,393 nonbacterial infections, nervous system and viral meningitis EXCEPT WITH MCC 2.6115
01401 viral meningitis WITHOUT CC 1.3956 || | 01402 viral meningitis S CC 1.6389
01403 viral meningitis with MCC 2.1422
01,411 non-traumatic disorders of consciousness and coma WITHOUT CC 0.5813
01,412 non-traumatic disorders of consciousness and coma with CC 0.8185 || | 01,413 non-traumatic disorders of consciousness and coma with MCC 1.7999
01421 epileptic seizures WITHOUT CC 0.4418
01422 S epileptic seizures CC 0.5438
01423 S epileptic seizures MCC 0.8431
01,431 migraine HEADACHES AND OTHER WITHOUT CC 0.4398
01,432 migraine and other headaches with CC 0.5550
01,433 migraine and other headaches with MCC 0.6509
01441 cranial and intracranial INJURY WITHOUT CC 0.7257
01442 cranial and intracranial INJURY S CC 1.1406
01443 cranial and intracranial INJURY WITH MCC 2.7311
01451 concussion WITHOUT CC 0.2307
01452 concussion S CC 0.2584 || | 01453 concussion MCC, 0.4538
01,461 OTHER nervous system disorders WITHOUT CC 0.4324
01462 OTHER Nervous System Disorders With CC 0.6089
01463 Other disorders of nervous system MCC 0.9435
02011 enucleation and performance on the eyecups WITHOUT CC 1.0383
02,012 enucleation and the performance of orbit with CC 1.3054
02,013 enucleation and the performance of orbit with MCC 1.6643
02021 extraocular enforcement, other than ORBIT WITHOUT CC 0.2927
02022 extraocular enforcement, other than ORBIT S CC 0.4503
02023 extraocular enforcement, other than of orbit with MCC 0.4503
02,031 intraocular PERFORMANCE, EXCEPT THEM WITHOUT CC 0.6557
02032 intraocular enforcement, other than a lens with CC 0.7938 || | 02033 intraocular enforcement, other than a lens with MCC 0.7938
02041 performance on Cocco WITH OR WITHOUT vitrectomy WITHOUT CC 0.4299
02042 performance on Cocco WITH OR WITHOUT vitrectomy with CC 0.4610
performance on 02043 Cocco WITH OR WITHOUT vitrectomy with MCC 0.4619
02301 ACUTE AND Severe infections of the eye without CC 0.3707
02302 ACUTE A serious eye infection with CC 0.4798
02303 ACUTE A serious eye infection with MCC 0 , 4798
02311 Neurological and vascular disorders of the eye WITHOUT CC 0.4214
02312 Neurological and vascular disorders of the eye's CC 0.4816
02313 Neurological and vascular disorders of the eye's MCC 0.6952
02321 OTHER DISORDERS EYES WITHOUT CC 0.2344
02322 OTHER INCIDENTS WITH EYE CC 0.2827
02,323 Other disorders of the eye's MCC 0.3200
03011 high output in the larynx and trachea WITHOUT CC 2.9997
03012 GREAT performance on the larynx and trachea S CC 3.0006
03013 high output in the larynx and trachea with MCC 5.7917
03021 OTHER GREAT PERFORMANCES head and neck WITHOUT CC 2.6335
03022 OTHER GREAT power per capita AND NECK WITH CC 3.2034
03,023 OTHER GREAT PERFORMANCES AT THE HEAD AND NECK WITH MCC 5.0658
03031 performance on facial bones, EXCEPT LARGE CAPACITY head and neck WITHOUT CC 1.4016 03,032
performance on facial bones, except large output per head and neck CC 1.4780
03033 performance on facial bones, except large output per head and neck MCC 3.4247
03041 performance on the mouth without CC 0.6923 || | 03042 PERFORMANCE mouth with CC 0.7476 03,043
performance on the mouth with MCC 1.3394

03051 PERFORMANCE IN A mastoid cavities WITHOUT CC 1.0143
03052 PERFORMANCE IN A mastoid cavities S CC 1.1226
03053 PERFORMANCE IN A mastoid cavities with MCC 1.2163 03,061
performance on salivary gland WITHOUT CC 0.9867
03062 performance on the salivary glands S CC 1.2277
03063 salivary gland performance on MCC, 1.3596
03071 AXLE cleft lip and palate WITHOUT CC 1.2686
03072 AXLE cleft lip and palate S CC 1.4112
03,073 REMEDY cleft lip and palate with MCC 1.7296 03,081
performance on the tonsils and adenoids WITHOUT CC 0.4214 03,082
performance on the tonsils and adenoids S CC 0.5062 03,083
performance on the tonsils and adenoids with MCC 0.8374
03,091 OTHER PERFORMANCE IN disorders and diseases of ears, nose, mouth and throat without CC 0.4259
03092 OTHER PERFORMANCE IN disorders and diseases ears, nose, mouth and throat with CC 0.6033
03093 OTHER PERFORMANCE IN disorders and diseases of ears, nose, mouth and throat with MCC 0.7086
03301 Malignant diseases of the ear, nose, mouth and throat WITHOUT CC 0 , 7435 03,302
Malignant diseases of the ear, nose, mouth and throat with CC 0.7435
03303 Malignant diseases of the ear, nose, mouth and throat with MCC 0.7809
03,311 balance disorders WITHOUT CC 0.4410 | 03312 || balance disorders S CC 0.5038
03,313 balance disorders with MCC
0.5755 03,321 0.2421 epistaxis WITHOUT CC
03322 epistaxis S CC 0.3070
03,323 epistaxis MCC, 0, 3275
03,331 epiglottitis, otitis media, upper respiratory tract infection, laryngotracheitis WITHOUT CC 0.3231
03332 epiglottitis, otitis media, upper respiratory tract infection, laryngotracheitis S CC 0.4456
03,333 epiglottitis, otitis media, upper respiratory tract infection, laryngotracheitis with MCC 0.6402 03,341
diseases of the teeth and mouth WITHOUT CC 0.5474 03,342
diseases of the teeth or mouth CC 0.5842 03,343
diseases of the teeth or mouth MCC 0.7430
03351 Other disorders of the ears, nose, mouth and throat without CC 0.3383
03,352 Other disorders of the ears, nose, mouth and throat with CC 0.4106
03,353 Other disorders of the ears, nose, mouth and throat S MCC 0.5304
04011 GREAT thoracosurgeries WITHOUT CC 3.4076
04012 GREAT thoracosurgeries S CC 3.9881
04013 GREAT thoracosurgeries With MCC 5.2641
04021 SMALLER thoracosurgeries WITHOUT CC 2 , 5979
04022 SMALLER thoracosurgeries S CC 2.5979
04023 SMALLER thoracosurgeries With MCC 5.2657
04031 OTHER PERFORMANCE IN disorders and diseases of the respiratory system WITHOUT CC 1.2306
04,032 OTHER PERFORMANCE IN disorders and diseases of the respiratory system S CC 1.7486
04,033 OTHER PERFORMANCE IN disorders and diseases of the respiratory system with MCC 3.3768
04,301 cystic fibrosis WITHOUT CC 2.1607
04,302 cystic fibrosis S CC 2.1607 | || 04,303 cystic fibrosis The MCC
2.6905 04,310 2.4289 respiratory failure
04,321 pulmonary embolism WITHOUT CC 1.1086 04,322
pulmonary embolism S CC 1.1895 04,323
pulmonary embolism with MCC 1 , 3371
04331 SEVERE TRAUMA WITHOUT CHEST CC 0.4038
04332 SEVERE TRAUMA WITH CHEST CC 0.7931
04333 SEVERE TRAUMA CHEST WITH MCC 1.1914
04,341 Malignant diseases of the respiratory system without CC 0, 7543
04,342 Malignant respiratory diseases S CC 0.8506
04,343 Malignant respiratory diseases with MCC 0.9825
04351 infection and inflammation of the respiratory system WITHOUT CC 1.2209
04352 infection and inflammation of the respiratory system With CC 1.3948
04353 infection and inflammation of the respiratory system with MCC 2.2808
04,361-FREE pneumonia and whooping cough WITHOUT CC 0.7136
04,362-FREE pneumonia and whooping cough S CC 0.9445
04,363 FREE FROM pneumonia and whooping cough MCC, 1.3027 04,371
chronic obstructive pulmonary disease WITHOUT CC 0.6605 04,372
chronic obstructive pulmonary disease S CC 0.7581
04373 Chronic obstructive pulmonary disease with MCC 1.0640
04,381 asthma and bronchiolitis have NO CC 0.4877

04,382 asthma and bronchiolitis CC 0.6479
04,383 asthma and bronchiolitis MCC 0.8657
04,391 interstitial lung disease WITHOUT CC 0.9078
04,392 interstitial pulmonary disease with CC 0.9078 || | 04393 interstitial pulmonary disease with MCC 1.1605
04401 effusion, pneumothorax and pleuran WITHOUT CC 0.9671
04,402 pleuran pneumothorax and effusion with CC 1.1360
04403 pleuran pneumothorax and effusion with MCC 1.4248 | || 04,411 signs, symptoms and diagnoses of respiratory WITHOUT CC 0.4793
04412 SIGNS, SYMPTOMS AND DIAGNOSIS OF OTHER rESPIRATORY SYSTEM WITH CC 0.6728
04,413 SIGNS, SYMPTOMS AND DIAGNOSIS OF OTHER rESPIRATORY SYSTEM WITH MCC 0.9356
05000 DEATH TO 5 DAYS TO RECEIVE AT HOME diagnoses circulatory system 0.7058
05,011 cardiac defibrillator implants and TO SUPPORT THE HEART WITHOUT CC 46.0957
05,012 cardiac defibrillator implants AND SUPPORT FOR THE HEART WITH CC 47 , 8379
05,013 cardiac defibrillator implants and TO SUPPORT THE HEART WITH MCC 48.5657 05,021
performance on a heart valve cardiac catheterization WITHOUT CC 15.5867 05022
performance on a heart valve cardiac catheterization S CC 17 6303
05,023 performance on a heart valve cardiac catheterization MCC, 05031 20.3528
OPERATIONS AND PROCEDURES FOR Congenital heart defects without CC 8.4209
05032 OPERATIONS AND PROCEDURES FOR Congenital heart defects CC 9.1790 | || 05 033 OPERATIONS AND PROCEDURES FOR Congenital heart defects MCC 26.6641 05,041
performance on a heart valve cardiac catheterization WITHOUT WITHOUT CC 12.6280 05,042
performance on a heart valve WITHOUT cardiac catheterization S CC 13.7030
05,043 performance on a heart valve WITHOUT cardiac catheterization with MCC 16.9153
05051 SE coronary bypass cardiac catheterization WITHOUT CC 10.2044
05,052 coronary bypass cardiac catheterization S CC 11.2292
05,053 coronary bypass cardiac catheterization With MCC 11.9894
05,061 coronary bypass cardiac catheterization WITHOUT WITHOUT CC 8.5047
05062 WITHOUT coronary bypass cardiac catheterization S CC 8.9443
05,063 coronary bypass WITHOUT cardiac catheterization with MCC 10.2279
05070 PERMANENT IMPLANTATION the pacemaker in acute myocardial infarction, heart failure or shock, 6.7519
05081 OTHER cardiothoracic performance without CC 5.5751
cardiothoracic 05,082 OTHER PERFORMANCE WITH CC 6.1246
cardiothoracic 05,083 OTHER PERFORMANCE WITH MCC 6 , 6188
05091 MAJOR ABDOMINAL VASCULAR performance without CC 6.1744
05092 MAJOR ABDOMINAL VASCULAR exercising with CC 7.6120
05093 MAJOR ABDOMINAL VASCULAR exercising with MCC 8.4032
05101 OTHER DURING PERCUTANEOUS cardiovascular procedures acute myocardial MYOKARDUBEZ CC 4.9088
05,102 OTHER PERCUTANEOUS cardiovascular procedures for acute myocardial MYOKARDUS CC 4.9353
05103 OTHER PERCUTANEOUS cardiovascular procedures for acute myocardial MYOKARDUS MCC 6.1002
05111 IMPLANTATION WITHOUT CONSTANT Pacemakers acute myocardial infarction , heart failure or shock, WITHOUT CC 5.1472
05112 IMPLANTATION WITHOUT CONSTANT Pacemakers acute myocardial infarction, heart failure and shock with CC 5.1472
05,113 IMPLANTATION WITHOUT CONSTANT Pacemakers acute myocardial infarction, heart failure and shock with MCC 5 , 3298
05121 BIG CHEST VASCULAR performance without CC 9.2647
05122 GREAT PERFORMANCES WITH CHEST VASCULAR CC 11.7015
05123 GREAT PERFORMANCES WITH CHEST VASCULAR MCC 13.5436
05131 OTHER PERCUTANEOUS cardiovascular procedures WITHOUT acute myocardial infarction without CC 3.7008
05132 OTHER PERCUTANEOUS cardiovascular procedures without acute myocardial infarction CC 3.7008
05133 OTHER PERCUTANEOUS cardiovascular procedures without acute myocardial infarction MCC 4.4394
05,141 other vascular performance without CC 2.9333
05,142 other vascular exercising with CC 3.2492
05143 other vascular exercising with MCC 4.3541
05,151 amputations due to a failure of the circulatory system, EXCEPT upper limbs and toes WITHOUT CC 2.0198
05,152 amputations due to a failure of the circulatory system, EXCEPT upper limbs and toes S CC 2.7498

05,153 amputations due to a failure of the circulatory system, EXCEPT upper limbs and toes with MCC 3.7596
05,161 Pacemakers EXCHANGE WITHOUT CC 3.7663
05162 EXCHANGE Pacemakers S CC 3.7663
05163 EXCHANGE Pacemakers With MCC 3.9647
05,171 amputation A toe FOR circulatory disorders SYSTÉMUBEZ CC 1.4258
05,172 amputation A toe FOR circulatory disorders SYSTÉMUS CC 1.8629
05,173 amputation A toe FOR circulatory disorders SYSTÉMUS MCC 3.0048
05181 CONTROL pacemakers and defibrillators, EXCEPT FOR REPLACEMENT OF EQUIPMENT BEZCC 1.1741
05182 CONTROL pacemakers and defibrillators, EXCEPT FOR REPLACEMENT OF EQUIPMENT WITH CC 1.7448
05183 CONTROL pacemakers and defibrillators, EXCEPT FOR REPLACEMENT OF EQUIPMENT WITH MCC 2.1279
05,191 ligatures STRIPPING AND VASCULAR WITHOUT CC 0.6347
05,192 ligatures and STRIPPING vessels with CC 0.6941
05,193 ligatures and STRIPPING vessels with MCC 0
7626 05201 OTHER PERFORMANCE IN diseases and disorders of the circulatory system WITHOUT CC 1.0020
05202 OTHER PERFORMANCE IN diseases and disorders of the circulatory system S CC 1.5374
05203 OTHER PERFORMANCE IN diseases and disorders of the circulatory system with MCC 2 , 7699
05,221 percutaneous coronary angioplasty,> = 3 film-coated stents in AKUTNÍMINFARKTU infarction without CC 13.7387
05,222 percutaneous coronary angioplasty,> = 3 film-coated stents in AKUTNÍMINFARKTU CC 15.3386 infarction with percutaneous coronary
05223 angioplasty,> = 3 film-coated stents in AKUTNÍMINFARKTU infarction MCC 15.3386
05231 percutaneous coronary angioplasty <= 2 film-coated stents in AKUTNÍMINFARKTU infarction without CC 7.2501
05232 percutaneous coronary angioplasty <= 2 film-coated stents in AKUTNÍMINFARKTU infarction CC 7.4203
05,233 percutaneous coronary angioplasty <= 2 film-coated stents in AKUTNÍMINFARKTU infarction MCC 7.7945
05241 percutaneous coronary angioplasty,> = 3 stents in acute myocardial infarction without CC 9.9320 | || 05,242 percutaneous coronary angioplasty,> = 3 stents in acute myocardial infarction with CC 9.9320
05,243 percutaneous coronary angioplasty,> = 3 stents in acute myocardial infarction with MCC 10.3960
05251 PERCUTANEOUS catheter ablation in acute myocardial infarction without CC 4.7981
05,252 PERCUTANEOUS catheter ablation for acute myocardial infarction with CC 4.7981
05253 PERCUTANEOUS catheter ablation for acute myocardial infarction with MCC 17.7399
05,261 percutaneous coronary angioplasty,> = 3 COATED STENTS without acute myocardial infarction without CC 11.2001
05,262 percutaneous coronary angioplasty,> = 3 COATED STENTS without acute myocardial infarction CC 11.4560
05263 percutaneous coronary angioplasty,> = 3 COATED STENTS WITHOUT acute myocardial infarction With MCC 12.2904
05,271 percutaneous coronary angioplasty <= 2 COATED STENTS without acute myocardial infarction without CC 6.5131
05,272 percutaneous coronary angioplasty <= 2 COATED STENTS without acute myocardial infarction CC 6.6607 | || 05,273 percutaneous coronary angioplasty <= 2 COATED STENTS without acute myocardial infarction MCC 7.1593
05,281 percutaneous coronary angioplasty,> = 3 STENTS without acute myocardial infarction without CC 8.7769
05,282 percutaneous coronary angioplasty, > = 3 STENTS without acute myocardial infarction CC 8.7769
05,283 percutaneous coronary angioplasty,> = 3 STENTS without acute myocardial infarction MCC 9.1680
05,291 PERCUTANEOUS catheter ablation without acute myocardial infarction without CC 5.3384
05,292 PERCUTANEOUS catheter ablation without acute myocardial infarction CC 6.0070
05293 PERCUTANEOUS catheter ablation without acute myocardial infarction MCC 6.0910
05301 cardiac catheterization for acute myocardial infarction without CC 1.3137
05302 cardiac catheterization for acute myocardial infarction with CC 1.4136

05,303 cardiac catheterization for acute myocardial infarction with MCC 1.8839
05311 cardiac catheterization in ischemic heart disease WITHOUT CC 0.8125
05,312 cardiac catheterization in ischemic heart disease with CC 0.8857
05313 HEART CATHETERIZATION in ischemic heart disease with MCC 1.0018

05321 cardiac catheterization in other disorders of the circulatory system WITHOUT CC 1.2083
05,322 cardiac catheterization in other disorders of the circulatory system S CC 1.3230
05323 cardiac catheterization in other disorders of the circulatory system with MCC 1.9420 || | 05331 acute myocardial infarction without CC 0.6474
05,332 acute myocardial infarction CC 0.9531
05,333 acute myocardial infarction MCC 1.4959
05341 Acute and subacute endocarditis WITHOUT CC 1.7267
05342 Acute and subacute endocarditis S CC 2.7569
05,343 acute and subacute endocarditis with MCC 5.4522
05351 HEART FAILURE WITHOUT CC 0.7517
05352 HEART FAILURE WITH CC 0.8396
05353 HEART FAILURE WITH MCC 1.2092
05361 deep vein thrombosis WITHOUT CC 0.5608
05362 deep vein thrombosis S CC 0.6449
05363 deep venous thrombosis with MCC 0.8353
05,371 of unexplained cardiac arrest WITHOUT CC 1.3635
05372 unexplained cardiac arrest with CC 1.7272
05,373 of unexplained cardiac arrest with MCC 3.8679
05,381 PERIPHERAL VASCULAR DISORDERS AND OTHER WITHOUT CC 0.5965
05,382 PERIPHERAL VASCULAR AND OTHER Faults with CC 0.6954
05,383 PERIPHERAL VASCULAR AND OTHER INCIDENTS WITH MCC
0.8727 05,391 0.5272 artherosclerosis without CC 05,392
atherosclerosis CC
0.6455 05,393 0.9589 atherosclerosis MCC
05401 hypertensive CC
0.4188 05,402 0.4876 hypertension with CC
05403 hypertension with MCC 0.5988 05,411
congenital heart and valvular disorder without CC 0.4305
05412 Congenital Heart A heart valve disorder with CC 0.7011 05,413
congenital heart and valvular disorder with MCC 1.1964
05,421 cardiac arrhythmias and conduction disturbances WITHOUT CC 0.5120
05,422 cardiac arrhythmias and conduction disturbances S CC 0.6590
05,423 cardiac arrhythmias and conduction disturbances with MCC 0.9003
05431 angina and chest pain WITHOUT CC 0.4455
05432 angina and chest pain S CC 0.5437
05433 angina and chest pain with MCC 0.6562
05,441 syncope and collapse of NO CC 0.4038
05,442 syncope, and collapse with CC 0.5430
05443 syncope and collapse of MCC, 0.6507
05451 CARDIOMYOPATHY WITHOUT CC 0.6063
05452 cardiomyopathies with the CC
0.7313 05,453 0.8526 cardiomyopathies with the MCC
05461 FAILURE, AND REACTION Vascular complications of heart OR DEVICES OR PERFORMANCE WITHOUT CC 0.5297
05,462 FAILURE response and complications of heart Vascular OR DEVICES OR PERFORMANCE WITH CC 0.5297
05463 FAILURE, AND REACTION Vascular complications of heart OR DEVICES OR PERFORMANCE WITH MCC 1.4590
05471 OTHER circulatory disorders WITHOUT CC 0.5427 || | 05472 OTHER circulatory disorders S CC 0.7119
05473 Other disorders of the circulatory system with MCC 1.1784
06011 Big performance for thick and thin intestine without CC 3.9323
06012 Big performance for thick and thin intestine with CC 4.4746
06013 Big performance for thick and thin intestine with MCC 6.4722
06021 high output in the stomach, esophagus and duodenum WITHOUT CC 3.1334
06022 high output in the stomach, esophagus A duodenum S CC 4.5609
06023 high output in the stomach, esophagus and duodenum with MCC 5.2921
06031 less power for thick and thin intestine without CC 1.7904
06032 less power on the large and small intestine With CC 2.5445
06033 less power for thick and thin intestine with MCC 4.0516
06041 peritoneal adhesions RELEASE NO CC 1.1665 06,042
RELEASE adhesions of the peritoneum S CC 1.4353 06,043
RELEASE adhesions of the peritoneum with MCC 2.1029
06051 performance on appendix WITHOUT CC 0.9904
06052 performance on appendix S CC 1.2202
06053 appendix S performance on MCC 1.9131
laparoscopic surgery IN 06061 TANNING, thigh, umbilical or epigastric Kyle WITHOUT CC 1.3216

06062 IN TANNING laparoscopic surgery, thigh, umbilical or epigastric Kyle CC 1.4789
06063 IN TANNING laparoscopic surgery, thigh, umbilical or epigastric Kyle MCC 1.5593
06071 LOWER performance on the stomach, esophagus and duodenum WITHOUT CC 2.2790
06,072 less power ON stomach, esophagus and duodenum S CC 2.6217
06073 LOWER performance on the stomach, esophagus and duodenum with MCC 3.0123
06081 laparotomy performance at TANNING, THIGH, umbilical or epigastric Kyle WITHOUT CC 0.7033
06082 laparotomy performance at TANNING, thigh, umbilical or epigastric Kyle CC 0.9513
06083 laparotomy performance at TANNING, thigh, umbilical or epigastric Kyle MCC 1, 2796
06091 anal STOMIC performance without CC 0.5682 06,092
anal STOMIC PERFORMANCE WITH CC 0.6623
06093 anal STOMIC of performance with MCC 0.9858
06101 OTHER PERFORMANCE IN disorders and diseases digestive system WITHOUT CC 1.0892
06,102 OTHER PERFORMANCE IN disorders and diseases of the digestive system S CC 1.7635
06103 OTHER PERFORMANCE IN disorders and diseases of the digestive system with MCC 3.0824
06111 PERFORMANCE IN THE complicating appendix HOME diagnosis without CC 1.2734
06112 performance on appendix AT HOME complicating diagnoses CC 1.7836 06,113
performance on appendix AT HOME complicating diagnosis with MCC 2.9462
06301 Malignant diseases of the digestive system without CC 0 , 5141 06,302
Malignant Disorders of the digestive system S CC 0.6485
06,303 Malignant Disorders of the digestive system with MCC 0.7593
06,311 Peptic ulcers and gastritis WITHOUT CC 0.4015
06,312 Peptic ulcers and gastritis S CC 0.7071
06,313 Peptic ulcers and gastritis with MCC 1.0049
06,321 DISORDERS esophagus without CC 0.3836
06,322 DISORDERS esophageal CC 0.5514
06,323 DISORDERS esophageal MCC 0.9304
06331 diverticulitis, diverticulosis, inflammatory bowel disease WITHOUT CC 0.5026
06332 diverticulitis, diverticulosis, inflammatory bowel disease S CC 0.6145
06333 diverticulitis, diverticulosis, inflammatory bowel disease with MCC 1.2012 || | 06341 VASCULAR impairment of the gastrointestinal system without CC 0.1764
06342 VASCULAR impairment of the gastrointestinal system S CC 0.3576
06343 VASCULAR impairment of the gastrointestinal system with MCC 1.2657
06,351 OBSTRUCTION gastrointestinal system without CC 0.4200 | || 06352 OBSTRUCTION gastrointestinal system S CC 0.5342
06353 OBSTRUCTION gastrointestinal system with MCC 0.9304
06,361 serious infections of the gastrointestinal system without CC 0.7290
06,362 serious infections of the gastrointestinal system S CC 1.0075 | || 06,363 serious infections of the gastrointestinal system with MCC 3.7929
06371 OTHER gastroenteritis and abdominal pain WITHOUT CC 0.2844
06372 OTHER gastroenteritis and abdominal pain with CC 0.4061
06,373 OTHER gastroenteritis and abdominal pain with MCC 0.5439
06,381 OTHER disorders of the digestive system without CC 0.3291
06,382 Other disorders of the digestive system S CC 0.4775
06383 Other disorders of the digestive system with MCC 0.6878
07011 operations of the pancreas , liver and coupler CC 3.8394
07012 operations of the pancreas, liver and clutch with CC 5.0159
07013 operations of the pancreas, liver and clutch with MCC 8.1933
07021 GREAT PERFORMANCES biliary WITHOUT CC 3.5566
07022 GREAT PERFORMANCES biliary S CC 4.1339
07,023 high output in the biliary tract MCC 5.4844
07031 cholecystectomy, Laparoscopic EXCLUDING WITHOUT CC 1.6819
07032 cholecystectomy, Laparoscopic EXCEPT WITH CC 2.1678
07033 cholecystectomy, Laparoscopic EXCEPT WITH MCC 3.5492
07041 Laparoscopic cholecystectomy WITHOUT CC 1.4261
07042 Laparoscopic cholecystectomy S CC 1.6610
07,043 laparoscopic cholecystectomy With MCC 2.0356

07,051 OTHER PERFORMANCE IN disorders and diseases hepatobiliary system and pancreas WITHOUT CC 1.6583
07,052 OTHER PERFORMANCE IN disorders and diseases hepatobiliary system and pancreas S CC 2.5559
07,053 OTHER PERFORMANCE IN disorders and diseases hepatobiliary system A pancreas MCC 4.0825
07301 cirrhosis and alcoholic hepatitis WITHOUT CC 0.6375
07302 cirrhosis and alcoholic hepatitis S CC 0.7619
07303 cirrhosis and alcoholic hepatitis With MCC 1.0429 07,311
malignant Disease hepatobiliary system and pancreas WITHOUT CC 0.6151
07,312 MALIGNANCIES hepatobiliary system and pancreas S CC 0.7500
07,313 MALIGNANCIES hepatobiliary system and pancreas with MCC 0.8568
07,321 DISORDERS pancreatic malignancy EXCEPT DISEASE WITHOUT CC 0.7389
07,322 DISORDERS pancreatic malignancy EXCEPT WITH CC 1.0269
07,323 DISORDERS pancreatic malignancy EXCEPT WITH MCC 2.0003 07,331
liver disorders, in addition to malignant cirrhosis and alcoholic hepatitis WITHOUT CC 0.4969 07,332
liver disorders, in addition to malignant cirrhosis and alcoholic hepatitis S CC 0.6940
07333 liver disorders, in addition to malignant cirrhosis and alcoholic hepatitis With MCC 1.0188
07,341 Other disorders of the biliary tract WITHOUT CC 0.5364
07,342 Other disorders of the biliary tract with CC 0.7450
07,343 Other disorders of the biliary tract with MCC 1.0184
08011 spinal fusions and scoliosis deformities IN NO CC 7.8775
08012 SPINAL FUSION WHEN deformities and scoliosis S CC 7.8775
08013 spinal fusion AT deformities and scoliosis with MCC 7.8775
08021 BILATERAL AND MULTI-high output in the lower extremity joints without CC 5.9997
08022 BILATERAL AND MULTIPLE LARGE performances on lower extremity joints SCC 7.7960
08023 BILATERAL AND MULTI-high output in the lower limbs SMCC 08031 10.0354
spinal fusions, NE deformities WITHOUT CC 5.0770
08032 spinal fusion, not deformity CC 6.2103
08033 spinal fusion, not for the deformity MCC 6.3886
08041 GREAT PERFORMANCES lower extremity replantation AND THEIR JOINT WITHOUT CC 3.5702
08042 GREAT PERFORMANCES lower limb replantation of their joints With CC 3.5967
08043 GREAT PERFORMANCES lower extremity replantation AND THEIR JOINT WITH MCC 4.2769
08051 reconstructive surgery for cranial and facial bones WITHOUT CC 2.5432
08,052 reconstructive surgery for cranial and facial bones with CC 3 , 8406
08053 reconstructive surgery for cranial and facial bones with MCC 4.3272
08061 GREAT PERFORMANCES upper extremity replantation AND THEIR JOINT WITHOUT CC 2.1719
08062 GREAT PERFORMANCES upper extremity replantation AND THEIR JOINT WITH CC 3, 6577
08063 GREAT PERFORMANCES upper extremity replantation AND THEIR JOINT WITH MCC 3.6577
08,071 amputations AT musculo-skeletal disorders and connective tissue NO CC 2.6599
08072 amputation AT musculo-skeletal disorders and connective tissue SCC 2, 6599
08,073 amputations AT musculo-skeletal disorders and connective tissue SMCC 5.0958
08081 performance on the hip and femur, EXCEPT replantation of large joints WITHOUT CC 2.3201 08,082
performance on the hip and femur, EXCEPT replantation large joints SCC 2.7616
08083 performance on the hip and femur, EXCEPT replantation of large joints SMCC 3.3957 08,091
skin grafting or tissue for musculo-skeletal disorders SYSTÉMUNEBO connective tissue EXCEPT HAND 0.6814
WITHOUT CC 08,092
skin grafting or tissue for musculo-skeletal disorders SYSTÉMUNEBO connective tissue EXCEPT HAND 1.7800
With CC
08093 TRANSPLANTATION skin or tissue disorders 4.7414
Musculoskeletal or connective tissue EXCEPT HAND WITH MCC
08101 performance on the back of the neck, EXCLUDING MERGER spine without CC 1,5776
08102 performance on the back of the neck, EXCLUDING MERGER WITH SPINAL CC 2.2343
08103 PERFORMANCE BACK AND nECK, EXCLUDING MERGER WITH SPINAL MCC 2.9574 08,111
performance on knees, legs and hocks, EXCEPT FOR FOOT WITHOUT CC 1.2641

08,112 performance on knees, legs and hocks, EXCEPT WITH FOOT CC 1.6507 08,113
performance on knees, legs and hocks, EXCEPT WITH FOOT MCC 2.1328
08121 removal of internal fixation devices without CC 0, 4401
08122 removal of internal fixation device S CC 0.5010
08123 removal of internal fixation device with MCC 0.6182 LOCAL
08131 resection of the musculoskeletal system WITHOUT THE CC 0.7672 LOCAL
08132 resection ON the musculoskeletal system With CC 1.1115 LOCAL
08,133 resection of the musculoskeletal system ON WITH MCC 1.7296 08,141
performance on feet WITHOUT CC 0.5754
08142 performance on the foot with CC 0.6573 08,143
performance on feet With MCC 0.8369
08151 PERFORMANCE upper extremities WITHOUT CC 0.7720 08,152
performance on the Upper extremities The CC 1.1966
08153 Upper extremities performance on MCC, 1.7927
performance on 08161 SOFT TISSUE WITHOUT CC 0.5934 08,162
performance on soft tissue with CC 0.8040 08,163
performance on soft tissue with MCC 1.3125
08171 OTHER PERFORMANCE IN disorders and diseases of the musculoskeletal system and connective tissue without CC 0.8190
08,172 OTHER PERFORMANCE IN disorders and diseases of the musculoskeletal system and connective tissue with CC 1.0555
08,173 OTHER PERFORMANCE IN disorders and diseases of the musculoskeletal system and connective tissue with MCC 2.2936
08181 GREAT PERFORMANCE ON stifles WITHOUT CC 4.3768
08,182 high output in the knee joint with CC 4.5513
08,183 high output in the knee joint with MCC 4.7556
08191 arthroscopy WITHOUT CC 0.6199
08192 arthroscopy With CC 0.6302
08193 arthroscopy with MCC 0.7104
08301 Thigh bone fractures WITHOUT CC 0.6163
08302 Thigh bone fractures S CC 0.8046
08,303 bone fractures WITH THIGH MCC 1, 1075
08311 pelvic fractures, dislocations HIP WITHOUT CC 0.5803
08312 pelvic fractures, dislocations of the hip CC 0.7539
08313 pelvic fractures, dislocations of the hip MCC 1.0513 08,321
fractures, dislocations, EXCEPT femurs and pelvis WITHOUT CC 0.3462
08322 fractures, dislocations, EXCEPT femurs and pelvis S CC 0.4960
08,323 fractures, dislocations, EXCEPT femurs and pelvis with MCC 0.6052
08,331 MALIGNANCIES musculoskeletal and connective tissue disorders, pathological fractures, WITHOUT CC 0.6245
08332 MALIGNANCIES musculoskeletal and connective tissue disorders, pathological fractures, S CC 0.8470
08,333 Malignant Disorders of the musculoskeletal system and connective tissue, pathological fractures with MCC 0.9947
08341 osteomyelitis WITHOUT CC 0.4113
08,342 osteomyelitis S CC
1.0967 08,343 3.0015 osteomyelitis with MCC
08351 septic arthritis without CC 0.6813 || | 08352 septic arthritis with CC 1.2865
08353 septic arthritis MCC, 1.9127
08361 connective tissue disorders WITHOUT CC 0.8083
08362 connective tissue disorders S CC 0.8083 08,363
disorder of the connective Tissues with MCC 1.0667
08,371 of conservative treatment of back problems WITHOUT CC 0.5240
08,372 of conservative treatment of back problems with CC 0.6085
08,373 of conservative treatment of back problems with MCC 0.6966 || | 08381 OTHER bone and joint disease WITHOUT CC 0.5682
08,382 other diseases of bones and joints S CC 0.6305
08,383 other diseases of bones and joints with MCC 0.7700
08,391 FAILURE, reactions and complications of orthopedic DEVICES OR PERFORMANCE WITHOUT CC 0.5316
08,392 FAILURE, reactions and complications of orthopedic DEVICES OR PERFORMANCE WITH CC 0.6138
08393 FAILURE, reactions and complications of orthopedic DEVICES OR PERFORMANCE WITH MCC 0.8861
08401 Musculo-skeletal symptoms symptoms, sprains and less significant inflammatory diseases WITHOUT CC 0.3942
08402 MUSCULOSKELETAL signs, symptoms, sprains and less significant inflammatory diseases S CC 0.5432
08403 MUSCULOSKELETAL signs, symptoms, sprains and less significant inflammatory diseases S MCC 0.7443

08,411 Other disorders of the musculoskeletal system and connective tissue without CC 0.3660
08412 Other disorders of the musculoskeletal system and connective tissue with CC 0.5977
08,413 Other disorders of the musculoskeletal system and connective tissue with MCC 0.7404 || | 09011 Skin grafts AND / OR WITHOUT debridement CC 0.6291 09,012
skin grafts AND / OR debridement S CC 1.0252
09013 Skin grafts AND / OR debridement with MCC 1.3553
09021 PERFORMANCE breasts WITHOUT CC 0.9055
09022 PERFORMANCE breasts with CC 1.1280
09,023 PERFORMANCE breasts with MCC 1.1396
09031 OTHER PERFORMANCE IN disorders and diseases of the skin, subcutaneous tissue and breast WITHOUT CC 0.4793
09032 OTHER PERFORMANCE IN disorders and diseases of the skin, subcutaneous tissue and breast CC 0.8028
09,033 OTHER PERFORMANCE IN disorders and diseases of the skin, subcutaneous tissue and breast MCC 1.1057
09301 SERIOUS INCIDENTS WITHOUT SKIN CC 0.6513
09302 SERIOUS INCIDENTS WITH SKIN CC 0.7297
09303 SERIOUS INCIDENTS WITH SKIN MCC 0.8711
09,311 Malignant breast disease WITHOUT CC 0.6592
09312 Malignant breast disease S CC 0 , 7083 09,313
Malignant breast disease with MCC
0.7294 09,321 0.5078 phlegmone WITHOUT CC
09322 phlegmone S CC
0.6999 09,323 0.8551 phlegmone MCC, 09,331
skin injury , subcutaneous tissue and breast WITHOUT CC 0.2483 09,332
injury to the skin, subcutaneous tissue and breast CC 0.3547 09,333
injury to the skin, subcutaneous tissue and breast MCC 0.5007
09,341 SKIN AND OTHER DISORDERS bREAST WITHOUT CC 0.3857
09,342 other type of skin and breast S CC 0.5308
09343 other type of skin cancer with MCC A 0.6018
10011 performance on the adrenal gland and the pituitary gland WITHOUT CC 2.7991 | 10012 || performance on the adrenal gland and the pituitary gland S CC 3.2324
10013 performance on the adrenal gland and the pituitary gland MCC, 4.8623
10021 skin grafts and debridement WOUNDS to endocrine, nutritional and metabolic disorders WITHOUT CC 1.7963
10022 Skin grafts and debridement WOUNDS to endocrine, nutritional and metabolic disorders S CC 2.4881
10023 skin grafts and debridement WOUNDS to endocrine, nutritional and metabolic disorders with MCC 2.7991
10031 PERFORMANCE WITHOUT obesity CC 3.1779
10032 PERFORMANCE FOR oBESITY WITH CC 4.7799
10033 PERFORMANCE FOR oBESITY WITH MCC 9.3897
10,041 lower extremity amputations in endocrine, nutrition and METABOLICKÝCHPORUCHÁCH WITHOUT CC 1.7852
10042 amputations in endocrine, nutrition and METABOLICKÝCHPORUCHÁCH S CC 2.0970
10,043 lower extremity amputations in endocrine, nutrition and METABOLICKÝCHPORUCHÁCH MCC, 5.0699
10051 performance on the thyroid and parathyroid glands, THYROGLOSSÁLNÍ performance without CC 1.2936
10052 performance on the thyroid and parathyroid glands, THYROGLOSSÁLNÍ exercising with CC 1.4407
10053 performance on the thyroid and parathyroid glands, THYROGLOSSÁLNÍ exercising with MCC 1.6732
10061 other performances in endocrine, nutritional and metabolic disorders WITHOUT CC 2.3324
10062 other performances in endocrine, nutritional and metabolic disorders S CC 4.1343
10063 other performances in endocrine, nutritional and metabolic disorders with MCC 5.0648
10301 dIABETES, NUTRITION AND OTHER METABOLIC FAULTS WITHOUT CC 0.5206
10302 dIABETES, NUTRITION AND OTHER metabolic disturbances with CC 0.6220
10303 dIABETES, NUTRITION AND OTHER metabolic disturbances with MCC 0.8976
10311 volume and electrolyte disturbances WITHOUT CC 0, 4489
10312 volume and electrolyte disturbances S CC 0.5947
10313 volume and electrolyte disturbances with MCC 0.6719
10321 inborn errors of metabolism WITHOUT CC 0.5130
10322 inborn errors of metabolism S CC 0, 6316
10323 inborn errors of metabolism with MCC 0.8984
10331 other endocrine disorders WITHOUT CC 0.7248
10332 other endocrine disorders with CC 0.7248
10333 other endocrine disorders with MCC 1.0410 | 11011 || kidney transplant WITHOUT CC 7.8987

11,012 renal transplant CC 7.8987
11013 renal transplant MCC 9.9365
11021 high output in the bladder without CC 5.8933
11022 GREAT PERFORMANCES bladder S CC 6.5333
11023 GREAT PERFORMANCES bladder MCC, 8.4302
11031 high output in the kidneys and urinary tract WITHOUT CC 2.1400
11032 high output in the kidneys and urinary tract With CC 2.5876
11033 high output in the kidneys and urinary tract With MCC 3.1662
11041 OPERATING introduction or revision of catheters for peritoneal dialysis WITHOUT CC 1.4645
11042 OPERATING introduction or revision of catheters for peritoneal dialysis against CC 1.6856
11043 OPERATING introduction or revision of catheters for peritoneal dialysis against MCC 3.2730
11051 less power on kidneys, urinary tract and bladder without CC 0.9907
11052 less power on kidneys, urinary tract and bladder S CC 1, 1236
11053 less power on kidneys, urinary tract and bladder MCC, 1.6345
11061 pROSTATECTOMY WITHOUT CC 1.1383
11062 prostatectomy CC 1.3906
11063 prostatectomy MCC 1.8816
11071 URETHRAL and transurethral performance without CC 0,5767
11072 URETHRAL and transurethral PERFORMANCE WITH CC 0.6756
11073 URETHRAL and transurethral PERFORMANCE WITH MCC 0.8251
11081 OTHER PERFORMANCE IN disorders and kidney disease A urinary tract WITHOUT CC 0.8069
11082 OTHER PERFORMANCE IN disorders and diseases kidney and urinary tract With CC 0.8069
11083 OTHER PERFORMANCE IN disorders and diseases kidney and urinary tract With MCC 1.2181
11301 Malignant kidney and urinary tract and kidney failure not CC 0.4413
11302 Malignant kidney and urinary tract and kidney failure with CC 0.6159
11303 Malignant kidney and urinary tract and kidney failure with MCC 0.9639
11311 nephritis without CC 0.4134
11312 nephritis with CC 0.4134
11313 nephritis with MCC 0.8149
11321 kidney infection and urinary WITHOUT CC 0.4412
11322 kidney infection and urinary S CC 0.6097
11323 INFECTION kidney and urinary tract With MCC 0.8280
11331 urinary calculi with extracorporeal shock wave lithotripsy WITHOUT CC 0.4753
11332 urinary calculi with extracorporeal shock wave lithotripsy S CC 0.6161
11333 urinary calculi with extracorporeal shock wave lithotripsy with MCC 0.6434
11341 urinary calculi ESWL WITHOUT WITHOUT CC 0.3059
11342 urinary calculi ESWL WITHOUT S CC 0.4149 || | 11343 urinary calculi with ESWL WITHOUT MCC 0.5680
11351 FAILURE, REACTION AND COMPLICATIONS GENITOURETRÁLNÍHO INSTRUMENTS, graft or transplant WITHOUT CC 0.2711
11352 FAILURE, REACTION AND COMPLICATIONS GENITOURETRÁLNÍHO INSTRUMENTS, graft or transplant S CC 0 , 3696
11353 FAILURE, REACTION AND COMPLICATIONS GENITOURETRÁLNÍHO INSTRUMENTS, graft or transplant MCC, 0,6978
11361 SIGNS AND SYMPTOMS OF THE kidney and urinary tract WITHOUT CC 0.5984
11362 SIGNS AND SYMPTOMS kidney and urinary THE ROAD WITH CC 0.5984
11363 SIGNS AND SYMPTOMS OF THE kidney and urinary tract With MCC 0.5984
11371 Other disorders of kidney and urinary tract WITHOUT CC 0.3158
11372 Other disorders of kidney and urinary tract With CC 0.4089
11373 Other disorders of kidney and urinary tract With MCC 0.6168
12011 GREAT PERFORMANCES IN THE PAN U MEN WITHOUT CC 2.0799
12012 GREAT PERFORMANCES IN THE PAN male with CC 2.1016
12013 GREAT PERFORMANCES IN THE PAN male with MCC 2.8911
12021 performance on the penile CC 0.4802
12022 performance on the penis CC 0.8607
12023 performance on the penis MCC 0 , 9325
12031 TRANSURETHRAL pROSTATECTOMY WITHOUT CC 1.0610
12032 TRANSURETHRAL prostatectomy CC 1.2299
12033 TRANSURETHRAL prostatectomy MCC 1.4520
12041 PERFORMANCE testicular WITHOUT CC 0.5731

12042 performance on testicles CC 0.7268
12043 testicles performance on MCC 0.8941
12051 circumcision WITHOUT CC 0.4115
12052 circumcision S CC 0.4480
12053 circumcision S MCC 0.4837
12061 OTHER performance on male reproductive system without CC 0.6650
12062 other performances on the male reproductive system S CC 1.0336
12063 other performances on the male reproductive system with MCC 1.0336 | || 12301 Malignant diseases of the male reproductive system WITHOUT CC 0.4220
12302 Malignant diseases of the male reproductive system S CC 0.5051
12303 Malignant diseases of the male reproductive system with MCC 0.7955
12311 DISORDERS male reproductive system, EXCEPT malignancy WITHOUT CC 0.2201
12312 DISORDERS male reproductive system EXCEPT malignancy with CC 0.2840
12313 DISORDERS male reproductive system EXCEPT malignancy with MCC 0.3304
13011 pelvic exenterations, rADICAL radical hysterectomy and vulvectomy BEZCC 3.0954
13012 pelvic exenterations, radical hysterectomy and radical vulvectomy S CC 4.0901
13013 pelvic exenterations, radical hysterectomy and radical vulvectomy MCC, 4.0901
13021 Performance on the uterus adnexal for malignant disease ovarian adnexal AND WITHOUT CC 2.5121
13022 PERFORMANCE the uterus and adnexal malignant diseases ovarian adnexal S CC 3.2904
13023 PERFORMANCE the uterus and adnexal malignant diseases ovarian adnexal With MCC 3.3954
13031 PERFORMANCE the uterus and adnexa in malignancy other than ovarian adnexal AND WITHOUT CC 2.1505
13032 PERFORMANCE the uterus and adnexa in malignancy other than the ovaries and the adnexal S CC 2, 5726
13033 PERFORMANCE the uterus and adnexa in malignancy other than the ovaries and the adnexal MCC, 2.6217
13041 uterine adnexal A performance at CA in situ and benign diseases without CC 1.3913
A uterine 13042 adnexal performance at CA in situ and benign diseases with CC 1.6028
13043 uterine adnexal A performance at CA in situ and benign diseases with MCC 1.9712
13051 Gynecological laparoscopy or laparotomy sterilization without CC 0.6993 || | 13052 Gynecological laparoscopy or laparotomy sterilization CC 0.9633
13053 Gynecological laparoscopy or laparotomy sterilization MCC 1.9816
13061 Reconstructive surgery of the female reproductive system without CC 1.0805
13062 Reconstructive surgery of the female reproductive THE S CC 1.2620
13063 Reconstructive surgery of the female reproductive system with MCC 1.7724
13071 vaginal, cervical and VULVOVÉ performance without CC 0.3429
13072 vaginal, cervical and VULVOVÉ PERFORMANCE WITH CC 0, 4072
13073 vaginal, cervical and VULVOVÉ of performance with MCC 0.5613
13081 ENDOSCOPIC WITHOUT INTERRUPTION fallopian tubes CC 0.7171
13,082 ENDOSCOPIC INTERRUPTION fallopian tubes S CC 0.7529
13083 ENDOSCOPIC INTERRUPTION fallopian tubes with MCC 0 , 7801
13091 dilation, curettage and conisation WITHOUT CC 0.2669
13092 dilation, curettage and conisation S CC 0.2945
13093 dilation, curettage A cone biopsy with MCC 0.3799
13101 OTHER PERFORMANCE WHEN disorders and diseases of the female reproductive system without CC 1.1926
13102 OTHER PERFORMANCE IN disorders and diseases of female reproductive system S CC 1.3967
13103 OTHER PERFORMANCE IN disorders and diseases of female reproductive system with MCC 2.7919 || | 13301 Malignant Disorders of the female reproductive system WITHOUT CC 0.5082
13302 Malignant Disorders of the female reproductive system S CC 0.6347
13303 Malignant Disorders of the female reproductive system with MCC 0.8721

13311 INFECTION female reproductive system WITHOUT CC 0.3448
13312 INFECTION female reproductive system S CC 0.4221
13313 INFECTION female reproductive system with MCC 0.9415
13321 menstrual and other disorders of the female reproductive system WITHOUT CC 0.2279

13322 menstrual and other disorders of the female reproductive system S CC 0.3208
13323 menstrual and other disorders of the female reproductive system with MCC 0.4909
14601 caesareans WITHOUT CC 1.1417
14602 Caesarean CUT WITH CC 1.3649
14603 caesarean birth with MCC 1.5627
14611 vaginal delivery with sterilization AND / OR dilatation and curettage without CC 0.6274
14612 vaginal delivery with sterilization AND / OR dilation and curettage S CC 0.6541
14613 vaginal delivery with sterilization AND / OR dilation and curettage with MCC 0.8845

14621 vaginal deliveries enforcement, other than sterilization and / OR dilatation and curettage without CC 1.2644
14,622 vaginal deliveries enforcement, other than sterilization and / OR dilation and curettage S CC 3.5237
14,623 vaginal deliveries enforcement, other than sterilization and / OR dilation and curettage with MCC 3.5237
14631 vaginal delivery WITHOUT CC 0.4427
14,632 vaginal deliveries CC 0.5108
14633 vaginal deliveries MCC 0.5108
14641 abortion with dilatation and curettage, aspiration curettage hysterectomy OR WITHOUT CC 0.2440 14,642
abortion with dilatation and curettage, aspiration curettage hysterectomy SCC 0.3166, OR 14643
abortion with dilatation and curettage, aspiration curettage hysterectomy SMCC 0.3166, OR 14651
an abortion without the dilation and curettage, aspiration curettage OR HYSTEREKTOMIEBEZ CC 0.1070
14652 an abortion without the dilation and curettage, aspiration curettage OR HYSTEREKTOMIES CC 0.1245
14653 an abortion without the dilation and curettage, aspiration curettage OR HYSTEREKTOMIES MCC 0.1911
14661 postpartum or POPOTRATOVÉ diagnoses performance without CC 0, 2343
14662 postpartum POPOTRATOVÉ AND DIAGNOSIS WITH POWER S CC 0.2343
A POPOTRATOVÉ 14663 postnatal diagnoses of performance with MCC 0.3036
14671 postpartum or POPOTRATOVÉ diagnosis without power without CC 0.2283
14672 A POPOTRATOVÉ postnatal diagnosis without power S CC 0.2283
14673 postpartum or POPOTRATOVÉ diagnosis without exercising with MCC 0.2283
14681 ectopic pregnancy S PERFORMANCE WITHOUT CC 1.3296
14682 ectopic pregnancy with the performance of S CC 1 , 3296
14683 ectopic pregnancy with the performance of MCC, 4.4443
14691 ectopic pregnancy WITHOUT EXERCISE WITHOUT CC 0.9863
14692 ectopic pregnancy WITHOUT EXERCISE WITH CC 1.2506
14693 ectopic pregnancy WITHOUT EXERCISE WITH MCC 1.2881
14701 threatened abortion WITHOUT CC 0.3339
14702 threatened abortion S CC 0.4014
14703 threatened abortion with MCC 0.4014
14711 FAKE birth without CC 0.1379 || | 14712 FAKE births CC 0.1866
14713 FAKE BIRTH WITH MCC 0.1866
14721 OTHER prenatal diagnoses performance without CC 0.3190
14722 OTHER prenatal diagnoses of performance with CC 0.5547 || | 14723 OTHER prenatal diagnoses of performance with MCC 0.6514
14731 OTHER prenatal diagnosis without power without CC 0.2549
14732 OTHER prenatal diagnosis without power S CC 0.3739
14733 OTHER prenatal diagnosis without power S MCC 0.3739
15601 newborn dead or translated <= 5 days without CC 0.3395
15602 newborn dead or translated <= 5 days with CC 1.4020
15603 newborn dead or translated < = 5 days with MCC 2.3601
15611 newborn, with organ or extracorporeal membrane oxygenation WITHOUT CC 9.7958
15612 newborn, with organ or extracorporeal membrane oxygenation S CC 13.7171
15613 newborn, With organ or extracorporeal membrane oxygenation MCC, 15621 21.7959
newborn weight at birth <= 1000G, basic performance without CC 4.6100
15622 newborn weight at birth <= 1000G, basic WITH PERFORMANCE CC 4.6100
15623 newborn weight at birth <= 1000G, basic exercising with MCC 29.3655
15631 newborn weight at birth <= 1000G, without basic performance without CC 2.4523
15632 newborn weight at birth <= 1000G, WITHOUT ESSENTIAL PERFORMANCE WITH CC 22.5699

15633 newborn weight at birth <= 1000G, WITHOUT ESSENTIAL PERFORMANCE WITH MCC 27.6166
15641 newborn weight at birth 1000-1499G, basic performance without CC 8.2417
15642 newborn weight at 1000-1499G birth, SE baseload S CC 8.2417
15643 newborn weight at birth 1000-1499G, basic exercising with MCC 24.4180
15651 newborn weight at birth 1000-1499G WITHOUT baseload WITHOUT CC 10.3167
15652 newborn weight at birth 1000-1499G, WITHOUT ESSENTIAL PERFORMANCE WITH CC 10.3167
15653 newborn weight at birth 1000-1499G, WITHOUT ESSENTIAL PERFORMANCE WITH MCC 16.2261
15661 newborn weight at birth 1500-1999G, basic performance without CC 10.3065
15662 newborn weight at birth 1500-1999G, SE baseload S CC 10.3065
15663 newborn weight at birth 1500- 1999G, SE baseload MCC, 15671 17.7010
newborn weight at birth 1500-1999G, without basic performance without CC 4.4742
15672 newborn weight at birth 1500-1999G, WITHOUT ESSENTIAL PERFORMANCE WITH CC 6 , 0679
15673 newborn weight at birth 1500-1999G, WITHOUT ESSENTIAL PERFORMANCE WITH MCC 8.3881
15681 newborn weight at birth 2000-2499G, basic performance without CC 5.7657
15682 newborn, weight at birth 2000-2499G, SE baseload S CC 11.6927
15683 newborn weight at birth 2000-2499G, basic exercising with MCC 11.6927
15691 newborn weight at birth 2000-2499G WITHOUT BASIC PERFORMANCE WITHOUT CC 0.8450
15692 newborn weight at birth 2000-2499G, WITHOUT ESSENTIAL PERFORMANCE WITH CC 2.2470
15693 newborn weight at birth 2000-2499G, WITHOUT ESSENTIAL PERFORMANCE WITH MCC 4.2377 | 15701 || newborn weight at birth> 2499G, basic performance without CC 3.8103
15702 newborn weight at birth> 2499G, SE baseload S CC 10.6826
15703 newborn weight at birth> 2499G SE baseload MCC, 15711 12.9840
newborn weight at birth> 2499G, with a serious anomaly or hereditary condition without CC 0.5182
15712 newborn weight at birth> 2499G, with a serious anomaly or hereditary condition With CC 1.5529
15713 newborn weight at birth> 2499G, with a serious anomalies or inherited condition with MCC 2.7539
15720 newborn weight at birth> 2499G, SE respiratory distress syndrome 3.8718
15731 newborn weight at birth> 2499G, with the aspiration syndromes without CC 0.3867
15732 newborn weight at birth> 2499G, with aspiration syndrome and CC 0.4599
15733 newborn weight at birth> 2499G, S aspiration syndrome, with MCC 1.1772
15741 newborn weight at birth> 2499G, with congenital or perinatal infection WITHOUT CC 0.8133
15742 newborn weight at birth> 2499G, with congenital or perinatal infection with CC 0, 8133
15743 newborn weight at birth> 2499G, with congenital or perinatal infection with MCC 2.5083
15751 newborn weight at birth> 2499G, without basic performance without CC 0.3522
15752 newborn, WEIGHT childbirth> 2499G, WITHOUT ESSENTIAL PERFORMANCE WITH CC 0.4676
15753 newborn weight at birth> 2499G, WITHOUT ESSENTIAL PERFORMANCE WITH MCC 0.6047
16011 PERFORMANCE spleen WITHOUT CC 3.1087
16012 PERFORMANCE spleen S CC 3.3242
16013 performance on MCC spleen 4.1496
16021 OTHER PERFORMANCE FOR BLOOD DISEASES AND WITHOUT CC-forming organs 0.8319
16022 OTHER PERFORMANCE FOR BLOOD DISEASE AND TO forming organs With CC 1.0170
16023 OTHER performance for blood diseases and blood-forming organs ON WITH MCC 1.9572
16301 agranulocytosis WITHOUT CC 0.8656
16302 agranulocytosis S CC 1.6095
16303 agranulocytosis with MCC 2.6547
16311 clotting disorder WITHOUT CC 0.7986
16312 coagulation disorders S CC 0.9352
16313 clotting disorders with MCC 1.2680
16321 sickle cell anemia WITHOUT CC 0.6449
16322 sickle Cell anemia with CC 0.8816
16323 sickle Cell anemia with MCC 1.4041

16331 DISORDERS red blood cells, EXCEPT Sickle Cell Anemia WITHOUT CC 0.6970
16332 DISORDERS red blood cells, EXCEPT Sickle Cell Anemia With CC 0.7803
16333 DISORDERS red blood cells, EXCEPT Sickle Cell Anemia With MCC 1.0116 || | 16341 Other disorders of blood and blood-forming organs without CC 0.5438
16342 Other disorders of blood forming organs A S CC 0.7045
16343 Other disorders of blood and blood-forming AUTHORITIES MCC 1.1722
17011 Lymphoma and leukemia HIGH PERFORMANCE WITHOUT CC 1.0951
17012 Lymphoma and leukemia with high performance S CC 2.6149
17013 Lymphoma and leukemia with high performance with MCC 9.7222
17021 lEUKEMIA AND LYMPHOMA WITH ANOTHER PERFORMANCE WITHOUT CC 1.0212
17022 lEUKEMIA AND LYMPHOMA WITH ANOTHER POWER S CC 1.2358
17023 lEUKEMIA AND LYMPHOMA WITH ANOTHER PERFORMANCE WITH MCC 9.3140
17031 myeloproliferative disorders, and poorly differentiated tumors with high performance WITHOUT CC 1, 9256
17032 myeloproliferative disorders, and poorly differentiated tumors with high performance S CC 2.8383
17033 myeloproliferative disorders, and poorly differentiated tumors with high performance with MCC 4.0801
17041 myeloproliferative disorders, and poorly differentiated tumors with different power WITHOUT CC 1.6743
17042 myeloproliferative disorders, and poorly differentiated tumors with different power S CC 1.7879
17043 myeloproliferative disorders, and poorly differentiated tumors with different power with MCC 4.1351
17301 acute leukemia WITHOUT CC 1 1608
17302 acute leukemia S CC 1.1608
17303 acute leukemia with MCC 6.0028
17311 lEUKEMIA LYMPHOMA A non-acute WITHOUT CC 1.2042
17312 lymphoma, and non-acute leukemia with CC 1.4410
17313 lymphoma, and non-acute leukemia with MCC 2.6728
17321 RADIATION THERAPY WITHOUT CC 1.7733
17322 radiotherapy CC 1.7733
17323 radiotherapy MCC 1.8884
17331 chemotherapy without CC 0.8321
17332 chemotherapy CC 0.8718
17333 chemotherapy MCC 0.8798
17341 OTHER myeloproliferative disorders and the diagnosis of undifferentiated tumor without CC 0.6779
17342 OTHER myeloproliferative disorders and diagnosis of undifferentiated Tumours With CC 0.7758
17343 OTHER myeloproliferative disorders and the diagnosis of undifferentiated tumors with MCC 1.2019
18011 performance for infectious and parasitic diseases WITHOUT CC 0.3133
18012 performance for infectious and parasitic diseases S CC 4, 2360
18013 performance for infectious and parasitic diseases MCC, 18021 10.2361
performance for postoperative and posttraumatic infection without CC 1.4148
18022 performance for postoperative and posttraumatic INFECTION WITH CC 2.3217
18023 Performance for postoperative and posttraumatic INFECTION WITH MCC 6.9089
18301 septicemia in CC 1.1064
18302 septicemia S CC 1.4198
18303 septicemia With MCC 2.7238
18311 postoperative and posttraumatic infection without CC 0.8470
18312 postoperative and posttraumatic INFECTION WITH CC 0.9047
18313 postoperative and posttraumatic INFECTION WITH MCC 1.0322
18321 fever of unknown origin WITHOUT CC 0.4819
18322 fever of unknown origin S CC 0.6734
18323 fever of unknown origin with MCC 0.7767
18331 VIRAL DISEASES WITHOUT CC 0.4357
18332 viral infection CC 0.5360
18333 viral infection MCC 0.6011 | 18341 || other infectious and parasitic diseases WITHOUT CC 0.5264
18342 for other infectious and parasitic diseases S CC 0.9081
18343 other infectious and parasitic diseases with the MCC 1.4828
19011 surgical techniques, primary diagnosis MENTAL ILLNESS WITHOUT CC 1.3553
19012 surgical techniques, primary diagnosis MENTAL ILLNESS WITH CC 3.3482
19013 operational performance with the main diagnosis of a mental disease with MCC
5.0039 19,301 1.5307 schizophrenia without CC | 19302 || schizophrenia CC 1.9045
19303 schizophrenia MCC 1.9593
19311 psychosis WITHOUT CC 1.5600
19312 psychosis with CC 1.5600
19313 psychosis with the MCC 1.7877

19321 personality disorders and moods without CC 1.0554
19322 personality disorder and mood with CC 1.0554
19323 personality disorder and mood with MCC 1.1754
19331 BIPOLAR DISORDER WITHOUT CC 1.6886
19332 bipolar disorder with CC 1.8690
19333 bipolar disorder with MCC 2.9424
19341 depression without CC 0.8697
19342 DEPRESSION WITH CC 0.9131
19343 DEPRESSION WITH MCC 2.1077 | 19351 || acute reactions, psychosocial disorders and neuroses depressive EXCLUDING WITHOUT CC 0.6618
19352 acute reactions, psychosocial disorders and neuroses EXCEPT depressive S CC 0.6618
19,353 acute reactions, psychosocial disorders and neuroses depressive EXCEPT WITH MCC 0.9322
19361 organic mental disorders and mental retardation WITHOUT CC 0.9201
19,362 organic mental disorders and mental retardation S CC 0.9232
19363 organic mental disorders and mental retardation with MCC 1.0283 || | 19371 DEVELOPMENTAL mental disorder without CC 1.1072
19372 DEVELOPMENTS WITH MENTAL DISORDERS CC 1.1072
19373 DEVELOPMENTS WITH MENTAL DISORDERS MCC 1.1072
19381 NUTRITION compulsive disorder without CC 2.4963
19382 NUTRITION compulsive disorder with CC 2.4963
19383 NUTRITION compulsive disorder with MCC 4.0557
19391 OTHER MENTAL DISORDERS WITHOUT CC 0.4927
19,392 OTHER MENTAL DISORDERS With CC 0.5810
19393 OTHER INTELLECTUAL Faults with MCC 1.5810
20301 harmful use of alcohol, medicines, drugs, addiction to them RELEASE RECOMMENDATIONS TO DOCTORS WITHOUT CC 0.1455
20302 harmful use of alcohol, medicines, drugs, addiction to them RECOMMENDATION AGAINST DISMISSAL Doctor with CC 0.1535
20303 harmful use of alcohol, medicines, drugs, addiction to them RELEASE against the advice of doctors with a MCC 0.3378
20311 addictions to drugs and alcohol rehabilitation AND / OR DETOX THERAPY WITHOUT CC 0 8000
20312 addictions to drugs and alcohol rehabilitation AND / OR DETOX THERAPY WITH CC 0.8571
20313 addictions to drugs and alcohol rehabilitation AND / OR DETOX THERAPY WITH MCC 1.1419
20321 MALICIOUS USE and dependence on opiates and / or cocaine WITHOUT CC 0.6231
20322 harmful use and addiction to opiates and / or cocaine S CC 0.6231
20323 harmful use and addiction to opiates and / or cocaine MCC S 0, 6337
20331 harmful use and alcohol dependence, WITHOUT CC 0.3592
20332 harmful use and alcohol dependence S CC 0.3976
20333 harmful use and alcohol dependence with MCC 0.8749
20341 MALICIOUS USE OF AND RELIANCE ON OTHER DRUGS WITHOUT CC 0.6657
20342 MALICIOUS USE OF AND RELIANCE ON OTHER DRUGS WITH CC 0.6657
20343 MALICIOUS USE OF AND RELIANCE ON OTHER DRUGS WITH MCC 0.9950
21011 microvascular LIVE tissue or skin grafts for injuries WITHOUT CC 0.7101
21012 microvascular tissue transfer or a skin graft injury with a CC 1.8355
21013 microvascular tissue transfer or a skin graft in accidents with MCC 6.3765
21021 OTHER PERFORMANCES for injuries and complications WITHOUT CC 1.5266
21022 other procedures for injuries and complications CC 4.0711
21023 other procedures for injuries and complications with MCC 9.3607
21301 for unspecified INJURY OR ON THE SPOT MORE PLACES CC 1.3489
21302 INJURY for unspecified site or at multiple sites with CC 1.6096
21303 INJURY for unspecified site or at multiple sites with MCC 3.4495
21311 ALLERGY WITHOUT CC 0 1991
21312 allergic reactions with CC 0.2619
21313 allergic reactions with MCC 0.5773
21321 poisoning and toxic effects of drugs (DRUG) NO CC 0.3118
21322 poisoning and toxic effects of drugs (Drugs), S CC 0.4805
21323 poisoning and toxic effects of drugs (drugs) With MCC 0.8658
21331 COMPLICATIONS IN TREATMENT WITHOUT CC 0.3057
21332 COMPLICATIONS IN TREATMENT WITH CC 0.4446 | || 21333 TREATMENT WITH COMPLICATIONS IN MCC 0.4446

21341 SYNDROME abused child or adult WITHOUT CC 0.3880
21342 SYNDROME abused child or an adult with CC 1.2111
21343 SYNDROME abused child or an adult with MCC 1.2111
21351 Other diagnoses INJURY poisoning and toxic effects of NO CC 0.3697
21,352 new diagnoses Injury, poisoning and toxic effects of S CC 0.4580
21353 Other diagnoses Injury, poisoning and toxic effects with MCC 0.7039
22501 bURNS, TRANSFER TO ANOTHER acute care facility WITHOUT CC 0.2719
22502 bURNS transferred to another acute care facility with CC 0.3623
22503 bURNS transferred to another acute care facility with MCC 0.3623
22510 EXTENSIVE bURNS With skin grafts 13.0452 22521
On small BURNS THROUGH entire skin, skin grafts or inhale. Injury without CC 2.8472
22522 On small BURNS THROUGH entire skin, skin grafts or inhale. With injuries CC 4.7451
22523 On small BURNS THROUGH entire skin, skin grafts or inhale. With injuries MCC 19.6430
22530 EXTENSIVE BURNS WITHOUT skin graft 3.1441
22541 BURNS limited scope covering all layers of skin, skin graft OR WITHOUT inhaled 0.7928
INJURY NOT CC
22542 BURNS limited scope covering all layers of skin, skin graft OR WITHOUT inhaled 1.2942
Injuries with CC
22543 BURNS limited scope covering all layers of skin, skin graft OR WITHOUT inhaled 1.3637
Injuries with MCC
22551 BURNS limited range of nonvertebral all skin layers WITHOUT CC 0.7701
22552 BURNS limited range of nonvertebral all skin layers with CC 1.0396
22553 BURNS limited range of nonvertebral all skin layers with MCC 1,
5156 23011 OPERATING PERFORMANCE diagnosed with any other contact with health SLUŽBAMIBEZ CC 0.7204
23012 OPERATING PERFORMANCE diagnosed with any other contact with health SLUŽBAMIS CC 1.7695
23013 OPERATING PERFORMANCE diagnosed with any other contact with health SLUŽBAMIS MCC 4 , 6257
23301 REHABILITATION WITHOUT CC 0.9305
23302 rehabilitation CC
1.0611 23,303 1.2576 rehabilitation MCC
23311 symptoms and abnormal finding without CC 0.3602
23312 SYMPTOMS and abnormalities S CC 0.5500
23313 symptoms and abnormal findings relating MCC 0.7169
23321 OTHER FACTORS AFFECTING MEDICAL CONDITION WITHOUT CC 0.2617
23322 other factors affecting the health status with CC 0.4803 | 23323 || other factors affecting the health status with MCC 0.8854
24010 HIV with the performance, with several severe infections with HIV associated 0.7860
24020 HIV S PERFORMANCE, WITH OTHER ASSOCIATED WITH HIV diagnoses 2.2196 || | 24031 HIV with power, without an additional diagnosis of HIV-associated WITHOUT CC 0.3359
24032 HIV with power, without an additional diagnosis of HIV-associated S CC 0.3359
24033 HIV S PERFORMANCE WITHOUT FURTHER DIAGNOSIS IN CONNECTION WITH HIV with MCC 0.3359
24301 HIV patients with ventilation or nutritional support without CC 0.6741
24302 HIV ventilating or nutritional support s CC 0.6741
24303 HIV ventilating or nutritional support with MCC 2.2010
24,311 HIV diagnoses WITH OTHER ASSOCIATED WITH HIV RELEASED THROUGH MEDICAL ADVICE WITHOUT CC 0.1417
24,312 HIV diagnoses WITH OTHER ASSOCIATED WITH HIV RELEASED THROUGH MEDICAL ADVICE S CC 0.1417
24313 HIV with other diagnoses ASSOCIATED WITH HIV RELEASED THROUGH MEDICAL ADVICE WITH MCC 0.1417
24320 HIV MULTI severe infections with HIV associated 14.8473
24331 HIV with other medical conditions associated with HIV, WITHOUT several serious infections associated with HIV, S 1 7500
Tuberculosis WITHOUT CC
24,332 HIV with other medical conditions associated with HIV, WITHOUT several serious infections associated with HIV, with 2.3538
Tuberculosis CC
24333 HIV with other medical conditions associated with HIV, WITHOUT several serious infections associated with HIV, with 2.3538
Tuberculosis MCC

24341 HIV with other medical conditions associated with HIV, WITHOUT several serious infections associated with HIV, WITHOUT 0.3749
TUBERCULOSIS WITHOUT CC
24,342 HIV with other medical conditions associated with HIV, WITHOUT several serious infections associated with HIV, WITHOUT 0.9323
Tuberculosis CC
24343 HIV with other medical conditions associated with HIV, WITHOUT several serious infections associated with HIV, WITHOUT 1.5668
Tuberculosis MCC
24350 HIV without additional diagnosis of HIV-associated 1.0059
25011 craniotomy, high output in the spine, hips and ends. In multiple serious TRAUMA WITHOUT CC 5.4702
25,012 craniotomy, high output in the spine, hips and ends. In multiple serious trauma CC 7.6954
25013 craniotomy, high output in the spine, hips and ends. In multiple serious trauma MCC 10.6315
25021 Other feats in multiple serious TRAUMA WITHOUT CC 4.4235
25,022 other performances in multiple serious trauma CC 4.4235
25023 Other feats in multiple serious trauma MCC 8.5132
25030 long-term mechanical ventilation in polytrauma> 1008 hours (more than 43 days) with ECO ROUGH 60.7653
PERFORMANCE
25040 long-term mechanical ventilation in polytrauma> 504 hours (22-42 days) with ECO ROUGH 41.4264
PERFORMANCE
25051 long-term mechanical ventilation in polytrauma> 240 hours (11 to 21 days) with ECO ROUGH 19.3273
Power without CC 25,052
long-term mechanical ventilation in polytrauma> 240 hours (11 to 21 days) with ECO ROUGH 23.3996
PERFORMANCE WITH CC
25053 long-term mechanical ventilation in polytrauma> 240 hours (11 to 21 days) with ECO ROUGH 26.4094
PERFORMANCE WITH MCC
25061 long-term mechanical ventilation in multiple trauma craniotomy with> 96 hours without CC 12.6369 25062
long-term mechanical ventilation in multiple trauma craniotomy S> 96 HOURS WITH CC 12.6369 25063
long-term mechanical ventilation in multiple injuries With craniotomy> 96 hours MCC, 25071 12.6369
long-term mechanical ventilation in polytrauma> 96 hours (5-10 days) with ECO POWER ROUGH 13.3207
WITHOUT CC
25072 long-term mechanical ventilation in polytrauma> 96 hours (5-10 days) with ECO POWER ROUGH 15.7159
With CC
25073 long-term mechanical ventilation in polytrauma> 96 hours (5-10 days) with ECO POWER ROUGH 15.7159
With MCC
25301 RELATING TO THE DIAGNOSIS head, chest and lower extremities in multiple serious TRAUMA WITHOUT CC 0.8105
25302 RELATING TO THE DIAGNOSIS head, chest and lower extremities in multiple serious trauma CC 0.9912
25303 ON THE DIAGNOSIS head, chest and lower extremities in multiple serious trauma MCC 2.2509
25311 OTHER diagnosis of multiple sERIOUS tRAUMA WITHOUT CC 0.5202
25312 OTHER sERIOUS diagnosis of multiple trauma CC 1.0905
25313 OTHER SERIOUS diagnosis of multiple trauma MCC 1.2129
25320 long-term mechanical ventilation in polytrauma> 1008 hour (MORE THAN 43 DAYS) 55.2000
25,330 long-term mechanical ventilation in polytrauma> 504 hours (22-42 DAYS) 46 , 3035
25341 long-term mechanical ventilation in polytrauma> 240 hours (11 to 21 days) without CC 19.0559
25,342 long-term mechanical ventilation in polytrauma> 240 hours (11 to 21 days) with CC 19.0559 || | 25343 long-term mechanical ventilation in polytrauma> 240 hours (11 to 21 days) with MCC 19.0559 25361
long-term mechanical ventilation in polytrauma> 96 hours (5-10 days) without CC 10.8875
25362 LONG MECHANICAL Ventilation When polytrauma> 96 hours (5-10 days) with CC 25363 10.8875
long-term mechanical ventilation in polytrauma> 96 hours (5-10 days) with MCC 18.8369
25370 DEATH IN 5 DAYS FROM RECEIPT WHEN polytrauma 1.6673
88,871 EXTENSIVE performance that are not related to the main diagnosis WITHOUT CC 0.6862
88,872 EXTENSIVE performance that are not related to the main diagnosis S CC 2.6356
88,873 EXTENSIVE power, which does not concern HOME diagnosis with MCC 6.4490
88881 prostatic performance that are not related to the main diagnosis WITHOUT CC 1.0695
88,882 prostatic performance that are not related to the main diagnosis S CC 2.9251

88883 prostatic performance that are not related to the main diagnosis MCC, 4.3550
88,891 PERFORMANCE limited extent, unrelated to principal diagnosis WITHOUT CC 0.6214
88,892 PERFORMANCE limited extent, unrelated to principal diagnosis S CC 1.3102
88,893 PERFORMANCE limited extent, unrelated to principal diagnosis with MCC 2.7069
99,980 primary diagnoses INVALID TO DISCHARGE DIAGNOSIS 0.3834 0.3517
99990 classified
----- --- ----------------------------------------------- -------------------------------------------------- - ---------------

Annex 10


Groups related to diagnosis by Klasifikace5) with indices of these groups
used to calculate CMalfa2008
----------- -------------- -------------------------------------------------- -------------------------------- ----------
IR-DRG5) name group Index
---------------------------------- ----------- -------------------------------------------------- ------------ ----------
01051 RELEASE carpal tunnel WITHOUT CC 0.1469
01052 RELEASE Carpal Tunnel S CC 0.1989
01053 RELEASE Carpal Tunnel With MCC 0.1989
01351 nonspecific stroke and precerebral OCCLUSION WITHOUT MYOCARDIAL WITHOUT CC 0.6841
01352 nonspecific stroke and precerebral OCCLUSION WITHOUT heart attack with CC 0.7719
01353 nonspecific VASCULAR precerebral stroke and heart attack with OCCLUSION WITHOUT MCC 1.1239
01361 TIA WITHOUT CC 0.4920
01362 TIA S CC 0.5690
01,363 transient ischemic attack with MCC 0.7237 || | 01421 epileptic seizures WITHOUT CC 0.4418
01422 S epileptic seizures CC 0.5438
01423 S epileptic seizures MCC 0.8431
01451 concussion WITHOUT CC 0.2307
01452 concussion S CC 0.2584
01453 concussion MCC, 0.4538
02321 OTHER DISORDERS eye without CC 0.2344
02322 OTHER INCIDENTS WITH EYE CC 0.2827
02,323 OTHER EYE DISORDERS WITH MCC 0.3200
03,061 performance on salivary gland WITHOUT CC 0.9867
03062 performance on the salivary glands S CC 1.2277
03063 salivary gland performance on MCC, 1.3596 03,081
performance on the tonsils and adenoids WITHOUT CC 0.4214 03,082
performance on the tonsils and adenoids S CC 0.5062 03,083
performance on the tonsils and adenoids with MCC 0.8374
03,311 balance disorders WITHOUT CC 0.4410
03312 DISORDERS EQUILIBRIUM S CC 0.5038
03,313 balance disorders with MCC
0.5755 03,321 0.2421 epistaxis WITHOUT CC
03322 epistaxis S CC
0.3070 03,323 0.3275 MCC, epistaxis
03341 diseases of the teeth and mouth WITHOUT CC 0.5474 03,342
diseases of the teeth or mouth CC 0.5842 03,343
diseases of the teeth or mouth MCC 0.7430
04351 infection and inflammation of the respiratory system WITHOUT CC 1.2209
04352 infection and inflammation of the respiratory system S CC 1.3948
04353 infection and inflammation of the respiratory system with MCC 2.2808
04,391 interstitial lung disease WITHOUT CC 0.9078
04,392 interstitial pulmonary disease with CC 0 , 9078
04,393 interstitial pulmonary disease with MCC 1.1605 05,021
performance on a heart valve cardiac catheterization WITHOUT CC 15.5867 05022
performance on a heart valve cardiac catheterization S CC 17.6303 05,023
Performance on cardiac valvular heart catheterization with MCC 20.3528 05,041
performance on a heart valve cardiac catheterization WITHOUT WITHOUT CC 12.6280 05,042
performance on a heart valve WITHOUT cardiac catheterization S CC 13.7030 05,043
performance on cardiac valve without cardiac catheterization with MCC 16.9153
05051 SE coronary bypass cardiac catheterization WITHOUT CC 10.2044
05,052 coronary bypass cardiac catheterization S CC 11.2292
05,053 coronary bypass cardiac catheterization with MCC 11 , 9894
05,061 coronary bypass cardiac catheterization WITHOUT WITHOUT CC 8.5047
05062 WITHOUT coronary bypass cardiac catheterization S CC 8.9443
05,063 coronary bypass WITHOUT cardiac catheterization with MCC 10.2279

05101 OTHER PERCUTANEOUS cardiovascular procedures after acute myocardial infarction without CC 4.9088
05,102 OTHER PERCUTANEOUS cardiovascular procedures after acute myocardial infarction CC 4.9353
05103 OTHER PERCUTANEOUS cardiovascular procedures after acute myocardial infarction MCC 6,
1002 05131 OTHER PERCUTANEOUS cardiovascular procedures without acute myocardial infarction without CC 3.7008
05132 OTHER PERCUTANEOUS cardiovascular procedures without acute myocardial infarction CC 3.7008
05133 OTHER PERCUTANEOUS cardiovascular procedures without acute myocardial infarction MCC 4 , 4394
05,151 amputations due to a failure of the circulatory system, EXCEPT upper limbs and toes WITHOUT CC 2.0198
05,152 amputations due to a failure of the circulatory system, EXCEPT upper limbs and toes with CC 2.7498 05,153
amputations due to a failure of the circulatory system, EXCEPT upper limbs and toes with MCC 3.7596
05,171 amputation A toe FOR circulatory disorders WITHOUT CC 1.4258
05,172 amputation A toe PRO circulatory disorders S CC 1.8629
05,173 amputation A toe FOR circulatory disorders with MCC 3.0048
05,191 ligatures STRIPPING AND VASCULAR WITHOUT CC 0.6347
05,192 ligatures and vessels with STRIPPING CC 0.6941
05,193 ligatures and STRIPPING vessels with MCC 0.7626
05,221 percutaneous coronary angioplasty,> = 3 film-coated stents in acute myocardial infarction without CC 13.7387
05,222 percutaneous coronary angioplasty,> = 3 COATED stents in acute myocardial infarction with CC 15.3386
05223 percutaneous coronary angioplasty,> = 3 film-coated stents in acute myocardial infarction with MCC 15.3386
05231 percutaneous coronary angioplasty <= 2 film-coated stents in acute myocardial infarction WITHOUT CC 7.2501
05232 percutaneous coronary angioplasty <= 2 film-coated stents in acute myocardial infarction with CC 7.4203
05,233 percutaneous coronary angioplasty <= 2 film-coated stents in acute myocardial infarction with MCC 7.7945 | || 05241 percutaneous coronary angioplasty,> = 3 stents in acute INFARKTUMYOKARDU WITHOUT CC 9.9320

05,242 percutaneous coronary angioplasty,> = 3 stents in acute INFARKTUMYOKARDU S CC 9.9320
05,243 percutaneous coronary angioplasty,> = 3 stents in acute INFARKTUMYOKARDU MCC, 10.3960
05251 PERCUTANEOUS catheter ablation for acute myocardial infarction without CC 4.7981
05,252 PERCUTANEOUS catheter ablation for acute myocardial infarction with CC 4.7981
05253 PERCUTANEOUS catheter ablation for acute myocardial infarction with MCC 17.7399
05,261 percutaneous coronary angioplasty,> = 3 COATED STENTS without acute myocardial infarction without CC 11.2001
05,262 percutaneous coronary angioplasty,> = 3 COATED STENTS without acute myocardial infarction CC 11.4560
05263 percutaneous coronary angioplasty,> = 3 COATED STENTS without acute myocardial infarction MCC 12.2904
05,271 percutaneous coronary angioplasty <= 2 COATED STENTS without acute myocardial infarction without CC 6.5131
05,272 percutaneous coronary angioplasty <= 2 COATED STENTS without acute myocardial infarction CC 6.6607 || | 05,273 percutaneous coronary angioplasty <= 2 COATED STENTS without acute myocardial infarction MCC 7.1593
05,281 percutaneous coronary angioplasty,> = 3 STENTS without acute myocardial infarction without CC 8.7769
05,282 percutaneous coronary angioplasty,> = 3 STENTS without acute myocardial infarction CC 8.7769
05,283 percutaneous coronary angioplasty,> = 3 STENTS without acute myocardial infarction MCC 9.1680
05,291 PERCUTANEOUS catheter ablation without acute myocardial infarction without CC 5.3384 | || 05292 PERCUTANEOUS catheter ablation without acute myocardial infarction CC 6.0070
05293 PERCUTANEOUS catheter ablation without acute myocardial infarction MCC 6.0910
05311 cardiac catheterization in ischemic heart disease WITHOUT CC 0.8125 05,312
cardiac catheterization in ischemic heart disease with CC 0.8857
05,313 cardiac catheterization in ischemic heart disease with MCC
1.0018 05,391 0.5272 artherosclerosis without CC 05,392
atherosclerosis CC 0.6455 05,393
atherosclerosis MCC 0.9589
05401 hypertensive CC 0.4188
05,402
hypertension with CC 0.4876
05403 hypertension with MCC 0.5988
06011 Big performance for thick and thin intestine without CC 3.9323
06012 Big performance for thick and thin intestine with CC 4 , 4746
06013 Big performance for thick and thin intestine with MCC 6.4722
06051 performance on appendix WITHOUT CC 0.9904
06052 performance on appendix S CC 1.2202
06053 PERFORMANCE IN appendix S MCC 1.9131
06061 IN TANNING laparoscopic surgery, thigh, umbilical or epigastric Kyle WITHOUT CC 1.3216
06062 IN TANNING laparoscopic surgery, thigh, umbilical or epigastric Kyle CC 1.4789
06063 laparoscopic surgery THE TANNING, thigh, umbilical or epigastric Kyle MCC 1.5593
06081 laparotomy performance at TANNING, thigh, umbilical or epigastric Kyle WITHOUT CC 0.7033
06082 laparotomy performance at TANNING, thigh, umbilical or epigastric Kyle CC 0.9513
06083 laparotomy performance at TANNING, thigh, umbilical or epigastric Kyle MCC 1.2796
06,311 Peptic ulcers and gastritis WITHOUT CC 0.4015
06,312 Peptic ulcers and gastritis S CC 0.7071
06,313 Peptic ulcers and gastritis with MCC 1.0049
06331 diverticulitis, diverticulosis, inflammatory bowel disease WITHOUT CC 0.5026
06332 diverticulitis, diverticulosis, inflammatory bowel disease S CC 0.6145
06333 diverticulitis , diverticular disease and inflammatory bowel disease with MCC 1.2012
06,351 OBSTRUCTION gastrointestinal system without CC 0.4200
06,352 OBSTRUCTION gastrointestinal system S CC 0.5342
06353 OBSTRUCTION gastrointestinal system with MCC 0.9304
06371 OTHER gastroenteritis and abdominal pain WITHOUT CC 0.2844
06372 OTHER gastroenteritis and abdominal pain with CC 0.4061
06,373 OTHER gastroenteritis and abdominal pain with MCC 0.5439
07031 cholecystectomy, Laparoscopic EXCLUDING WITHOUT CC 1 , 6819
07032 cholecystectomy, Laparoscopic EXCEPT WITH CC 2.1678
07033 cholecystectomy, Laparoscopic EXCEPT WITH MCC 3.5492
07041 Laparoscopic cholecystectomy WITHOUT CC 1.4261
07042 Laparoscopic cholecystectomy S CC 1.6610
07043 Laparoscopic cholecystectomy with MCC 2.0356
07,341 Other disorders of the biliary tract WITHOUT CC 0.5364
07,342 Other disorders of the biliary tract with CC 0.7450
07,343 Other disorders of the biliary tract with MCC 1.0184
08031 spinal fusions, NE deformities WITHOUT CC 5.0770
08032 spinal fusion, not for the deformity CC 6.2103
08033 spinal fusion, not for the deformity MCC 6.3886
08081 PERFORMANCE THE hip and femur, EXCEPT LARGE replantation KLOUBŮBEZ CC 2.3201 08,082
performance on the hip and femur, EXCEPT LARGE replantation KLOUBŮS CC 2.7616
08083 performance on the hip and femur, EXCEPT LARGE replantation KLOUBŮS MCC 3 , 3957
08101 performance on the back of the neck, EXCLUDING MERGER spine without CC 1,5776
08102 performance on the back of the neck, EXCLUDING MERGER WITH SPINAL CC 2.2343
08103 performance on the back of the neck, EXCLUDING MERGER spine MCC 2.9574
08121 removal of internal fixation devices without CC 0.4401 08,122
removal of internal fixation device S CC 0.5010
08123 removal of internal fixation device with MCC 0.6182
08191 arthroscopy WITHOUT CC 0.6199
08,192 arthroscopy S CC 0.6302
08193 arthroscopy with MCC 0.7104
08,371 of conservative treatment of back problems WITHOUT CC 0.5240
08,372 of conservative treatment of back problems with CC 0.6085
08,373 of conservative treatment of back problems with MCC 0,6966
09301 SERIOUS DISORDERS SKIN WITHOUT CC 0.6513
09302 SERIOUS INCIDENTS WITH SKIN CC 0.7297
09303 MAJOR Skin With MCC
0.8711 09,321 0.5078 phlegmone WITHOUT CC
09322 phlegmone S CC
0.6999 09,323 0.8551 MCC phlegmone S
09,341 OTHER Skin and Cancer without CC 0.3857
09,342 other type of skin and breast S CC 0.5308

09343 OTHER Skin and breast MCC 0.6018
10,041 lower extremity amputations in endocrine, nutritional and metabolic disorders WITHOUT CC 1.7852
10,042 lower extremity amputations in endocrine, nutritional and metabolic disorders S CC 2 , 0970
10,043 lower extremity amputations in endocrine, nutritional and metabolic disorders with MCC 5.0699
10051 performance on the thyroid and parathyroid glands, THYROGLOSSÁLNÍ performance without CC 1.2936
10052 performance on the thyroid and parathyroid glands, THYROGLOSSÁLNÍ power S CC 1.4407
10053 performance on the thyroid and parathyroid glands, THYROGLOSSÁLNÍ exercising with MCC 1.6732
10301 dIABETES, NUTRITION AND OTHER metabolic disorders WITHOUT CC 0.5206
10302 dIABETES, NUTRITION AND OTHER metabolic disturbances with CC 0.6220
10303 dIABETES, NUTRITION AND OTHER metabolic disturbances with MCC 0.8976
11051 less power on kidneys, urinary tract and bladder without CC 0.9907
11052 less power on kidneys , urinary tract and bladder S CC 1.1236
11053 less power on kidneys, urinary tract and bladder MCC, 1.6345
11061 pROSTATECTOMY WITHOUT CC 1.1383
11062 prostatectomy CC 1.3906
11063 prostatectomy MCC 1.8816
11071 URETHRAL and transurethral performance without CC 0,5767
11072 URETHRAL and transurethral PERFORMANCE WITH CC 0.6756
11073 URETHRAL and transurethral PERFORMANCE WITH MCC 0.8251 | 11321 || kidney infection and urinary WITHOUT CC 0.4412
11322 kidney infection and urinary S CC 0.6097
11323 INFECTION kidney and urinary tract With MCC 0.8280
11331 urinary calculi with extracorporeal lithotripsy shock wave WITHOUT CC 0.4753
11332 urinary calculi with extracorporeal shock wave lithotripsy S CC 0.6161
11333 urinary calculi with extracorporeal shock wave lithotripsy with MCC 0.6434
11341 urinary calculi ESWL WITHOUT WITHOUT CC 0.3059
11342 urinary calculi ESWL WITHOUT S CC 0.4149
11343 urinary calculi with ESWL WITHOUT MCC 0.5680
12021 performance on the penile CC 0.4802
12022 PERFORMANCE IN pENIS With CC 0.8607
12023 performance on the penis MCC 0.9325
12031 TRANSURETHRAL pROSTATECTOMY WITHOUT CC 1.0610
12032 TRANSURETHRAL prostatectomy CC 1.2299
12033 TRANSURETHRAL prostatectomy MCC 1.4520
12051 circumcision WITHOUT CC 0.4115
12052 circumcision S CC 0.4480
12053 circumcision MCC, 0.4837
13011 pelvic exenterations, radical hysterectomy and radical vulvectomy WITHOUT CC 3.0954
13012 pelvic exenterations, radical hysterectomy and radical vulvectomy SCC 4.0901
13013 pelvic exenterations, radical hysterectomy and radical vulvectomy SMCC 4.0901
13021 PERFORMANCE the uterus and adnexal for malignant disease ovarian adnexal AND WITHOUT CC 2.5121
13022 PERFORMANCE the uterus and adnexal malignant diseases ovarian adnexal S CC 3.2904
13023 PERFORMANCE the uterus and adnexal malignant diseases ovarian adnexal MCC, 3.3954
13051 Gynecological laparoscopy or laparotomy sterilization without CC 0.6993
13052 Gynecological laparoscopy or laparotomy sterilization CC 0.9633
13053 Gynecological laparoscopy or laparotomy sterilization MCC 1.9816
13071 vaginal, cervical and VULVOVÉ performance without CC 0.3429 | 13072 || vaginal, cervical and VULVOVÉ PERFORMANCE WITH CC 0.4072
13073 vaginal, cervical and VULVOVÉ of performance with MCC 0.5613
13081 ENDOSCOPIC WITHOUT INTERRUPTION fallopian tubes CC 0.7171
13,082 ENDOSCOPIC INTERRUPTION fallopian tubes S CC 0.7529
13083 ENDOSCOPIC INTERRUPTION fallopian tubes with MCC 0.7801
13091 dilation, curettage and conisation WITHOUT CC 0.2669
13092 dilation, curettage and conisation S CC 0.2945
13093 dilation, curettage A cone biopsy with MCC 0.3799
13311 INFECTION female reproductive system WITHOUT CC 0.3448
13312 INFECTION female reproductive system S CC 0.4221

13313 INFECTION female reproductive system with MCC 0.9415
14601 caesareans WITHOUT CC 1.1417
14602 caesareans S CC 1.3649
14603 caesarean birth with MCC 1.5627 | 14611 || vaginal delivery with sterilization AND / OR dilatation and curettage without CC 0.6274
14612 vaginal delivery with sterilization AND / OR dilation and curettage S CC 0.6541
14613 vaginal delivery with sterilization AND / OR dilation and curettage with MCC 0.8845
14631 vaginal birth WITHOUT CC 0.4427
14,632 vaginal deliveries CC 0.5108
14633 vaginal deliveries MCC 0.5108
14641 abortion with dilatation and curettage, aspiration curettage OR HYSTEREKTOMIÍBEZ CC 0.2440 14,642
abortion with dilatation and curettage, aspiration curettage OR HYSTEREKTOMIÍS CC 0.3166
14643 abortion with dilatation and curettage, aspiration curettage OR HYSTEREKTOMIÍS MCC 0.3166
14651 abortions with no dilatation A curettage, aspiration curettage hYSTERECTOMY OR WITHOUT CC 0.1070
14652 an abortion without the dilation and curettage, aspiration curettage and hysterectomy with CC OR 0.1245
14653 an abortion without the dilation and curettage, aspiration curettage and hysterectomy with MCC OR 0.1911
14701 threatened abortion WITHOUT CC 0.3339
14702 threatened abortion S CC 0.4014
14703 threatened abortion with MCC 0.4014
14711 FAKE birth without CC 0.1379
14712 FAKE BIRTH With CC 0.1866
14713 FAKE bIRTH WITH MCC 0.1866
15691 newborn weight at birth 2000-2499G, without basic performance without CC 0.8450
15692 newborn weight at birth 2000-2499G, WITHOUT ESSENTIAL PERFORMANCE WITH CC 2.2470
15693 newborn weight at birth 2000-2499G, WITHOUT ESSENTIAL PERFORMANCE WITH MCC 4.2377
15751 newborn weight at birth> 2499G, without basic performance without CC 0.3522 | 15752 || newborn weight at birth> 2499G, WITHOUT ESSENTIAL PERFORMANCE WITH CC 0.4676
15753 newborn weight at birth> 2499G, WITHOUT ESSENTIAL PERFORMANCE WITH MCC 0.6047
18311 postoperative and posttraumatic infection without CC 0 , 8470
18312 postoperative and posttraumatic INFECTION WITH CC 0.9047
18313 postoperative and posttraumatic INFECTION WITH MCC 1.0322
18331 VIRAL DISEASES WITHOUT CC 0.4357
18332 viral infection CC 0.5360
18333 viral infection MCC 0.6011
20301 harmful use of alcohol, medicines, drugs, addiction to them RELEASE RECOMMENDATIONS TO DOCTORS WITHOUT CC 0.1455
20302 harmful use of alcohol, medicines, drugs, drug THEREOF, TO RELEASE MEDICAL ADVICE S CC 0.1535
20303 harmful use of alcohol, medicines, drugs, addiction to them RELEASE against the advice of doctors with a MCC 0.3378
20331 harmful use and alcohol dependence, WITHOUT CC 0, 3592
20332 harmful use and alcohol dependence S CC 0.3976
20333 harmful use and alcohol dependence with MCC 0.8749
----------- ----- -------------------------------------------------- ----------------------------------------- --------- -

Annex 11


The amount of coverage for health care under § 7
-------- ----------------------------- -------------------------------------------------- --------------- ------------------
code name of the item above
payment
-------- -------------------------------------- -------------------------------------------------- ------------------ ------
00901 examination and treatment of patients registered 368 CZK
00902 Repeated examinations and treatments under the preventive care 294 CZK | || 00903 Requested examination specialist or specialist CZK 200
00904 Dental examination registered patient from 1 year to 6 years in the preventive care CZK 105
00906 registered patient Dental treatment under 6 years of age or hendikepovaného patient CZK 95
00907 dental treatment of registered patients aged 6 years to 15 years 68 CZK 00908
Acute treatment and examination of the patient as an unregistered expertise 019,295 CZK 00,909
clinical dental examination CZK 410
00,910 intraoral X-ray CZK 70

00911 Making extraoral radiographic CZK 225
00912 Contents salivary glands contrast agent 581 CZK 00913
Making orthopantomogram CZK 275
00914 Evaluation orthopantomogram 70 CZK 00915
Making telerentgenového picture of cranium 270 CZK
00916 Anesthesia for mandibular foramen and infraorbitale CZK 100
00917 Anesthesia infiltration 80 CZK 00920
treatment of dental caries - permanent tooth - photo composite filling 315 CZK 00921
treatment of dental caries - tooth permanent CZK 220
00,922 dental treatment caries - tooth temporary CZK 126
00923 Conservative treatment of complications of caries - tooth permanent CZK 181
00924 Conservative treatment of complications of caries - tooth temporary CZK 176
00925 Conservative treatment of complications of caries II- permanent tooth 265 CZK | || 00931 Conservative treatment of chronic periodontal disease CZK 700
00,932 Maintenance treatment of chronic periodontal disease is 243 CZK 00,933
Surgical treatment of periodontal disease small-scale
420 CZK 00934 Surgical treatment of periodontal disease is a large-scale 1000 CZK 00,935
curettage of the tooth 84 CZK
00936 Removing and ensure the transfer of transplant
600 CZK 00 937 CZK 433 Articulation teeth
00938 Temporary splints to stabilize teeth with periodontal disease CZK 44
00940 Complex examination and treatment proposal oral diseases 700 CZK 00,941
up examination and treatment of diseases of the oral mucosa 300 CZK 00,943
measurement of galvanic currents 88 CZK 00,945
Targeted examinations 10 CZK 00,946
examination and treatment of patients and registered 336 CZK 00,947
Retesting and treatment in the preventive care I
263 CZK 00949 deciduous tooth extraction CZK 87
00950 Extraction of permanent tooth 168 CZK 00951
surgery of hard tissues of the oral cavity minor CZK 525
00,952 surgery of hard tissues of the oral cavity large extent of CZK 1,155
00953 Surgical treatment of teeth retention CZK 630
00954 preservative-surgical treatment of complications of caries CZK 420
00955 Surgery of the soft tissues of the mouth of a small amount of 420 CZK 00956
surgery of soft tissues of the oral cavity large
range of 900 CZK 00957 Accident hard tissues of the mouth of a small amount of 420 CZK 00,958
Traumatology hard tissues of the oral cavity large range of CZK 750
00959 Intraoral incision CZK 105
00960 outer incision 600 CZK 00961 treatment
complications of surgical procedures in the oral cavity CZK 45
00962 Conservative treatment of temporomandibular joint disorders CZK 114
00963 Injection im, id, sc 53
CZK 00,965 dentists Time spent on transportation for immobile patient CZK 210
00966 Issuance of iD card PN or requests to support cares for a sick family member CZK 5
End PN 00967 or requests to support cares for a sick family member CZK 5
00968 dental treatment unregistered patients practical dentist - dental surgeon 1000 CZK
in healthcare facilities included in the network stomato workplaces
00970 Removal of fixed restorations - for each pillar design CZK 53
00971 Temporary protective crown in the office of CZK 69
00972 Repair fixed restorations in the office 72 CZK 00973 Repair or
adjustment of dentures in the office 39
CZK 00 974 Submission of dental products 0 CZK 00,975
protective bridge made swage method 607 CZK 00,981
orthodontic anomalies CZK 600
00,982 initiation of therapy with orthodontic anomalies fixed orthodontic appliances on one tooth arc 1300 CZK 00,983
Checking the treatment of orthodontic anomalies using fixed orthodontic appliance 800 CZK 00984
Checking the treatment of orthodontic anomalies using techniques other than using fixed orthodontic appliance 210 CZK

00985 Discontinuation of orthodontic anomalies using fixed orthodontic appliance CZK 700
00986 Discontinuation of orthodontic anomalies using techniques other than using fixed orthodontic appliance 348 CZK
00987 Determining growth stage 53 CZK 00,988
Analysis telerentgenového picture of cranium
116 CZK 00989 Analysis orthodontic models 315 CZK 00,990
Diagnostic rebuilding orthodontic model 473 CZK 00,991
Deploy prefabricated intraoral arch 173 CZK 00,992
Deploy extraoral traction or facial 210
CZK 00,993 Establishing partial arc CZK 300
-------- ------------------------------------- -------------------------------------------------- ------- ------------------


1) of Council Regulation (EC) no. 1408/71 of 14 June 1971 on the
social security schemes to employed persons and their families
moving within the Community and Council Regulation (EEC) No .
574/72 of 21 March 1972 laying down detailed rules for applying
(EEC) no. 1408/71 on the application of social security schemes to
employed persons and their families moving within Commonwealth.

2) For example, notification of the Ministry of Foreign Affairs no. 130/2002 Coll. m.
s., on Agreement between the Czech Republic and the Federal Republic of Yugoslavia
Social Security, Ministry of Foreign Affairs
no. 82/2000 Coll. ms of Agreement between the Czech Republic and the Republic of Croatia
Social Security, Communications of the Ministry of Foreign Affairs
no. 135/2004 Coll. ms of Agreement between the Czech Republic and
Republic of Turkey on social security, communication
Ministry of Foreign Affairs no. 2/2007 Coll. ms
on concluding a Treaty between the Czech Republic and the Republic of Macedonia on Social Security.

3) Decree no. 134/1998 Coll., Which publishes a list of medical procedures
with point values, as amended.

4) § 10 of Act no. 526/1990 Coll., On prices, as amended by Act no. 261/2007 Coll
.

Price Regulation of the Ministry of Health no. 5 amount 7 p. MZ.

5) The CSO no. 402/2008 Coll., On updating the classification
inpatients (IR-DRG).